| Gene (Std) |
Gene (Alternate Nomenclature) |
Accession |
System # |
Cluster |
Full Name |
|
| 1D12A |
1D12A |
L17325.1 |
6 |
Hs.278 |
pre-T/NK cell associated protein |
| Not approved by the HUGO/GDB Nomenclature Committee |
|
|
|
| ABCB7 |
ABC7, ASAT, Atmlp, EST140535 |
NM_004299.3 |
2 |
Hs.370480 |
ATP-binding cassette, sub-family B (MDR/TAP), member 7 |
|
|
|
|
| ABCC1 |
MRP1, GS-X, MRP |
NM_004996.2 |
5 |
Hs.391464 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
NM_019862.1 / NM_019898.1 / NM_019899.1 / NM_019901.1 / NM_019902.1 |
|
|
| ABCC10 |
MRP7, EST182763 |
U66684 |
5 |
Hs.55879 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 10 |
|
|
No Unigene Cluster Found (May 27, 2002). |
|
| ABCC3 |
MRP3, ABC31, CMOAT2, EST90757, MLP2, MOAT-D, Cmoat2 |
NM_003786.2 |
7 |
Hs.463421 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 - TRANSCRIPT VARIANTS MRP3, MRP3A, MRP3B |
|
|
|
|
| ABCC4 |
EST170205, MOAT-B, MOATB, MRP4 |
NM_005845.2 |
3 |
Hs.508423 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 4 |
|
|
|
|
| ABCC5 |
MRP5, ABC33, EST277145, MOAT-C, MOATC, SMRP |
NM_005688.2 |
5 |
Hs.368563 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 5 |
|
|
|
|
| ABCD2 |
ALD1, ALDL1, ALDR |
NM_005164.2 |
7 |
Hs.117852 |
ATP-binding cassette, sub-family D (ALD), member 2 |
|
|
|
|
| ABCF1 |
ABC50, EST123147 |
NM_001090.2 |
6 |
Hs.9573 |
ATP-binding cassette, sub-family F (GCN20), member 1 |
|
|
|
|
| ABCG1 |
ABC8, WHITE, WHITE1, WHT1 |
NM_016818.2 / NM_207174.1 / NM_004915.3 / NM_207627.1 / NM_207628.1 / NM_207629.1 |
4 |
Hs.124649 |
ATP-binding cassette, sub-family G (WHITE), member 1 |
|
|
|
|
| ABL |
ABL, JTK7, bcr/abl, c-ABL, p150 |
NM_005157.3 / NM_007313.2 |
14 |
Hs.431048 |
c-abl oncogene 1, receptor tyrosine kinase |
|
|
|
|
| ACE |
ACE1, DCP, DCP1 |
NM_000789.2 |
2 |
Hs.298469 |
dipeptidyl carboxypeptidase 1 (angiotensin I converting enzyme) |
|
TRANSCRIPT VARIANT 2: NM_152830.1
TRANSCRIPT VARIANT 3: NM_152831.1 |
|
|
| ACHE |
YT, ACHE |
NM_015831.2; NM_000665.3 |
1 |
Hs.154495 |
acetylcholinesterase (YT blood group) |
|
|
|
|
| ACSL1 |
FACL1, FACL2, LACS, LACS1, LACS2 |
NM_001995.2 |
7 |
Hs.406678 |
acyl-CoA synthetase long-chain family member 1 |
|
|
|
|
| ACTB |
beta-ACTIN |
NM_001101.2 |
1 |
Hs.426930 |
actin, beta |
|
|
|
|
| ACTN4 |
FSGS, FSGS1, ACT4 |
NM_004924.3 |
4 |
Hs.270291 |
actinin, alpha 4 |
|
|
|
|
| ACVR2B |
ActR-IIB |
NM_001106.3 |
3 |
Hs.517775 |
activin A receptor, type IIB |
|
|
|
|
| ADAM28 |
ADAM23,MDC-Lm,MDC-Ls |
NM_014265.3/NM_021777.2 |
9 |
Hs.528304 |
ADAM metallopeptidase domain 28 |
|
|
|
|
| ADAM9 |
ADAM12, KIAA0021, MCMP, MCMP-PEN, MDC9, Mltng |
NM_003816.2 / NM_001005845.1 |
3 |
Hs.2442 |
a disintegrin and metalloproteinase domain 9 (meltrin gamma) |
|
|
|
|
| ADH1A |
ADH1 |
NM_000667.2 |
7 |
Hs.368549 |
alcohol dehydrogenase 1A (class I), alpha polypeptide |
|
|
|
|
| ADH5 |
ADH3, ADH3, ADHX, FDH |
NM_000671.3 |
2 |
Hs.78989 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
|
|
|
|
| ADM |
AM |
NM_001124.1 |
3 |
Hs.441047 |
adrenomedullin |
|
|
|
|
| ADORA2B |
ADORA2B |
NM_000676.2 |
5 |
Hs.167046 |
adenosine A2b receptor |
|
|
|
|
| AES |
GRG |
NM_001130.5 |
2 |
Hs.515053 |
amino-terminal enhancer of split |
|
|
|
|
| AGT |
SERPINA8 |
NM_000029.2 |
3 |
Hs.19383 |
angiotensinogen |
|
|
|
|
| AKAP1 |
AKAP121, AKAP149, AKAP84, S-AKAP84 |
NM_003488.3 |
6 |
Hs.463506 |
a kinase (PRKA) anchor protein 1 - TRANSCRIPT VARIANTS 1 AND 2 |
|
|
|
|
| AKR1D1 |
SRD5B1 |
NM_005989.2 |
3 |
Hs.201667 |
aldo-keto reductase family 1, member D1 (delta -3-ketosteroid-5-beta-reductase) |
|
|
|
|
| ALAS1 |
ALASH, ALAS |
NM_000688.4 / NM_199166.1 |
1 |
Hs.476308 |
aminolevulinate, delta-, synthase 1 |
|
|
|
|
| ALDOC |
ALDC |
NM_005165.2 |
5 |
Hs.155247 |
aldolase C, fructose-bisphosphate |
|
|
|
|
| ALOX5 |
LOG5, 5-LIPOXY |
NM_000698.2 |
2 |
Hs.89499 |
arachidonate 5-lipoxygenase |
|
|
|
|
| AMBP |
HCP, ITI, ITIL |
NM_001633.2 |
5 |
Hs.436911 |
alpha-1-microglobulin/bikunin precursor |
|
|
|
|
| AMPH |
AMPH1, amphiphysin |
NM_001635.2 / NM_139316.1 |
7 |
Hs.173034 |
amphiphysin (Stiff-Mann syndrome w/ breast cancer 128 kD autoantigen)- TRANSCRIPT VARIANTS 1 AND 2 |
|
|
|
|
| ANXA1 |
ANX1, LCP1 |
NM_000700.1 |
3 |
Hs.494173 |
annexin A1 |
|
|
|
|
| ANXA4 |
ANX4 |
NM_001153.2 |
3 |
Hs.422986 |
annexin A4 |
|
|
|
|
| ANXA5 |
ANX5, ENX2, PP4, ANN V |
NM_001154.2 |
2 |
Hs.480653 |
annexin A5 |
|
|
|
|
| ANXA8 |
ANXA8 ($), ANX8 |
NM_001630.2 |
7 |
Hs.463110 |
annexin A8 |
|
|
|
|
| AP2B1 |
ADTB2, CLAPB1 |
NM_001282.2 |
6 |
Hs.514819 |
adaptor-related protein complex 2, beta 1 subunit |
|
|
|
|
| APOC3 |
Apo-CIII |
NM_000040.1 |
6 |
Hs.73849 |
apolipoprotein C-III |
|
|
|
|
| APOF |
apolipoprotein F |
NM_001638.2 |
3 |
Hs.534302 |
apolipoprotein F |
|
|
|
|
| APP |
A4, AAA, AD1, CVAP |
NM_000484.2 / NM_201413.1 / NM_201414.1 |
7 |
Hs.434980 |
amyloid beta (A4) precursor protein (protease nexin-II, Alzheimer disease) - TRANSCRIPT VARIANTS 1, 2, AND 3 |
|
|
|
|
| AQP3 |
AQP3 |
NM_004925.3 |
6 |
Hs.234642 |
aquaporin 3 |
|
|
|
|
| ARHGDIA |
GDIA, Rab-GDI |
NM_004309.3 |
4 |
Hs.159161 |
Rho GDP dissociation inhibitor (GDI) alpha |
|
|
|
|
| ARHGDIB |
D4, GDIA2, GDID4, Ly-GDI, RAP1GN1 |
NM_001175.4 |
3 |
Hs.504877 |
Rho GDP dissociation inhibitor (GDI) beta |
|
|
|
|
| ARHGEF5 |
TIM, TIM1 |
NM_005435.3 / NM_001002861.1 |
2 |
Hs.334 |
Rho guanine nucleotide exchange factor (GEF) 5 |
|
|
|
|
| ARNT |
HIF-1 beta, HIF1beta |
NM_001668.2 / NM_178427.1 |
1 |
Hs.131494 |
aryl hydrocarbon receptor nuclear translocator |
|
|
|
|
| ATF2 |
CRE-BP1, CREB2, CREBP1, TREB7 |
NM_001880.2 |
3 |
Hs.425104 |
activating transcription factor 2 |
|
|
|
|
| ATP1B2 |
AMOG |
NM_001678.3 |
3 |
Hs.78854 |
ATPase, Na+/K+ transporting, beta 2 polypeptide |
|
|
|
|
| ATP5G3 |
ATP5G3 |
NM_001689.1 |
3 |
Hs.429 |
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c (subunit 9) isoform 3 |
|
|
|
|
| ATP8B1 |
ATPIC, BRIC, FIC1, PFIC |
NM_005603.3 |
6 |
Hs.216623 |
ATPase, Class I, type 8B, member 1 |
|
|
|
|
| ATRN |
DPPT-L, MGCA, KIAA0548 |
NM_139321.1 |
6 |
Hs.276252 |
attractin - TRANSCRIPT VARIANTS 1, 2, AND 3 |
|
|
|
|
| B1 |
EFNB1, EPLG2, PTHB1, BBS9 |
NM_014451.3; NM_198428.2 |
6 |
Hs.372360 |
PTH-responsive osteosarcoma B1 protein |
| Not approved by the HUGO/GDB Nomenclature Committee 2/3/2003 |
|
|
|
| B2M |
B2M#, B2M |
NM_004048.2 |
14 |
Hs.534255 |
beta-2-microglobulin |
|
|
|
|
| BACE2 |
ALP56, DRAP,ASP1 |
NM_012105.3/NM_138991.1/NM_138992.1 |
9 |
Hs.529408 |
beta-site APP-cleaving enzyme 2 |
|
|
|
|
| BACH2 |
BTB, CNC |
NM_021813.1 |
6 |
Hs.269764 |
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
|
|
|
|
| BAD |
BBC6, BCL2L8, BBC2 |
NM_032989.1 / NM_004322.2 |
3 |
Hs.370254 |
BCL2-antagonist of cell death |
|
|
|
|
| BAG1 |
BAG1 (#), BAG1 |
NM_004323.4 |
7 |
Hs.377484 |
BCL2-associated athanogene |
|
|
|
|
| BAK1 |
BAK, BCL2L7, CDN1 |
NM_001188.3 |
5 |
Hs.485139 |
BCL2-antagonist / killer 1 |
|
|
|
|
| BAX |
BAX (%), BAX |
NM_138761.2 / NM_138763.2 / NM_138764.2 / NM_138765.2 |
7 |
Hs.159428 |
BCL2-associated X protein - TRANSCRIPT VARIANT ALPHA, DELTA, EPSILON, AND SIGMA |
|
|
|
|
| BCL2 |
BCL-2 |
NM_000633.2 |
1 |
Hs.150749 |
B-cell CLL/lymphoma 2 |
|
|
|
|
| BCL2L1 |
BCL-X, BCL2L, BCLX, Bcl-X, bck-xl, bcl-xS, BCL2-like 1 |
NM_138578.1 |
1 |
Hs.516966 |
BCL2-like 1 |
|
TRANSCRIPT VARIANT 2 : NM_001191.2 |
|
|
| BCL6 |
LAZ3, ZNF51 |
NM_001706.2 |
6 |
Hs.478588 |
B-cell CLL/lymphoma 6 (zinc finger protein 51) - TRANSCRIPT VARIANT 1 |
|
|
|
|
| BCL7B |
BCL7B |
NM_001707.2 / NM_138707.1 |
6 |
Hs.408219 |
B-cell CLL/lymphoma 7B - TRANSCRIPT VARIANTS 1 AND 2 |
|
|
|
|
| BCR |
ALL, CML, D22S11, PHL |
NM_004327.3 / NM_021574.2 |
14 |
Hs.517461 |
breakpoint cluster region |
|
|
|
|
| BCR/ABL b2a2 |
bcr/abl b2a2 |
AJ131467 |
14 |
|
|
|
|
|
|
| BCR/ABL b3a2 |
bcr/abl b3a2 |
AJ131466 |
14 |
|
|
|
|
|
|
| BGN |
DSPG1 |
NM_001711.3 |
3 |
Hs.821 |
biglycan |
|
|
|
|
| BMP2 |
BMP2A, |
NM_001200.2 |
6 |
Hs.73853 |
bone morphogenetic protein 2 |
|
|
|
|
| BMP6 |
VGR1, TGF-BETA |
NM_001718.3 |
3 |
Hs.285671 |
bone morphogenetic protein 6 |
|
|
|
|
| BMX |
ETK, PSCTK2, PSCTK3 |
NM_001721.4 |
3 |
Hs.495731 |
BMX non-receptor tyrosine kinase |
|
|
|
|
| BNIP3 |
NIP3 |
NM_004052.2 |
5 |
Hs.144873 |
BCL2/adenovirus E1B 19kD-interacting protein 3 |
|
|
|
|
| BRE |
BRE |
NM_004899.3 / NM_199194.1 / NM_199191.1 / NM_199193.1 / NM_199192.1 |
4 |
Hs.258314 |
brain and reproductive organ-expressed (TNFRSF1A modulator) |
|
|
|
|
| BST2 |
BST2 |
NM_004335.2 |
5 |
Hs.118110 |
bone marrow stromal cell antigen 2 |
|
|
|
|
| BTC |
BTC |
NM_001729.1 |
6 |
Hs.73105 |
betacellulin |
|
|
|
|
| BUB3 |
BUB3L |
NM_004725.2 / NM_001007793.1 |
2 |
Hs.418533 |
BUB3 (budding uninhibited by benzimidazoles 3, yeast) homolog |
|
|
|
|
| BZW1 |
KIAA0005, BZAP45 |
BC026303.1 |
6 |
Hs.355983 |
basic leucine zipper and W2 domains 1 |
|
|
|
|
| C10ORF7 |
FLJ13863, D123 |
AK023925.1 |
4 |
Hs.412842 |
chromosome 10 open reading frame 7 |
|
|
|
|
| C20ORF46 |
FL11190 |
NM_018354.1 |
6 |
Hs.516834 |
chromosome 20 open reading frame 46 |
|
|
|
|
| C3 |
C3 |
NM_000064.2 |
6 |
Hs.529053 |
complement component 3 |
|
|
|
|
| C4BPB |
C4BP |
NM_000716.3 / NM_001017364.1 |
6 |
Hs.99886 |
complement component 4-binding protein, beta |
|
|
|
|
| C6orf25 |
G6b, MGC142279, MGC142281, NG31 |
NM_025260.2 |
11 |
Hs.247879 |
chromosome 6 open reading frame 25 |
|
|
|
|
| CA3 |
CAIII |
NM_005181.2 |
7 |
Hs.82129 |
carbonic anhydrase III, muscle specific |
|
|
|
|
| CACNA2D3 |
HSA272268 |
NM_018398.2 |
|
|
calcium channel, voltage-dependent, alpha 2/delta 3 subunit |
|
|
|
|
| CALB2 |
CALB, CALB29, CAL, CAL2 |
NM_001740.2 / NM_007087.1 |
1 |
Hs.106857 |
calbindin 2, (29kD, calretinin) |
|
|
|
|
| CALCA |
CALC1 |
NM_001741.2 |
5 |
Hs.37058 |
calcitonin-related polypeptide alpha |
|
|
|
|
| CALM2 |
CAMII, PDHK, PHKD |
NM_001743.3 |
2 |
Hs.468442 |
calmodulin 2 (phosphorylase kinase, delta) |
|
|
|
|
| CALR |
CRTC, RO, SSA, cC1qR |
M84739.1 |
4 |
Hs.515162 |
calreticulin |
|
|
|
|
| CANX |
calnexin |
NM_001746.3 |
3 |
Hs.529890 |
calnexin |
|
|
|
|
| CAPG |
AFCP, MCP |
NM_001747.2 |
6 |
Hs.516155 |
capping protein (actin filament), gelsolin-like |
|
|
|
|
| CAPN3 |
CANP3, LGMD2, NCL1 |
NM_000070.2 / NM_024344.1 / NM_173087.1 / NM_173088.1 / NM_173089.1 / NM_173090.1 / NM_212465.1 / N |
7 |
Hs.143261 |
calpain 3, (p94) - TRANSCRIPT VARIANTS 1,2,3,4,5,6,7,8 AND 9 |
|
|
|
|
| CARS |
CARS |
NM_139273.2 / NM_001751.4 / NM_001014437.1 / NM_001014438.1 |
2 |
Hs.274873 |
cysteinyl-tRNA synthetase |
|
|
|
|
| CASP1 |
ICE, IL1BC, IL1BCE |
NM_033292.2 |
3 |
Hs.2490 |
caspase 1, apoptosis-related cysteine protease (interleukin 1, beta, convertase) |
|
TRANSCRIPT VARIANT BETA : NM_001223.3
TRANSCRIPT VARIANT DELTA : NM_033294.2 |
|
|
| CAST |
CAST |
NM_173060.2; NM_173061.2 |
7 |
Hs.440961 |
calpastatin - TRANSCRIPT VARIANTS 2 AND 3 |
|
|
|
|
| CAT |
Catalase |
NM_001752.2 |
1 |
Hs.502302 |
catalase |
|
|
|
|
| CBR1 |
CBR, CRN, Carbonyl Reductase |
NM_001757.2 |
1 |
Hs.88778 |
carbonyl reductase 1 |
|
|
|
|
| CBX1 |
CBX, HP1-BETA, HP1Hs-beta, M31, MOD1 |
BC002609.1 |
3 |
Hs.77254 |
chromobox homolog 1 (Drosophila HP1 beta) |
|
|
|
|
| CCNA2 |
CCN1, CCNA, CYCLIN A |
NM_001237.2 |
1 |
Hs.85137 |
cyclin A2 |
|
|
|
|
| CCND3 |
CYCLIN D3 |
NM_001760.2 |
2 |
Hs.534307 |
cyclin D3 |
|
|
|
|
| CCNE1 |
CCNE, G1/SPECIFIC CYCLIN E, cyclin E |
NM_001238.1 / NM_057182.1 |
3 |
Hs.244723 |
cyclin E1 |
|
|
|
|
| CCNG1 |
CCNG, CYCG1, CYCLIN G1 |
NM_004060.3 / NM_199246.1 |
2 |
Hs.79101 |
cyclin G1 |
|
|
|
|
| CCNG2 |
CYCLIN G2 |
NM_004354.1 |
1 |
Hs.13291 |
cyclin G2 |
|
|
|
|
| CCNH |
CAK, CYCLIN H |
NM_001239.2 |
1 |
Hs.146607 |
cyclin H |
|
|
|
|
| CCNI |
CYCLIN I |
NM_006835.2 |
2 |
Hs.518827 |
cyclin I |
|
|
|
|
| CCNK |
CPR4, cyclin k |
BC015935.1 |
5 |
Hs.510409 |
cyclin K |
|
|
|
|
| CCR1 |
CKR-1, CMKR1, CMKBR1, MIP1aR |
NM_001295.2 |
3 |
Hs.301921 |
chemokine (C-C motif) receptor 1 |
|
|
|
|
| CCT4 |
CCT4 |
NM_006430.2 |
5 |
Hs.421509 |
chaperonin containing TCP1, subunit 4 (delta) |
|
|
|
|
| CD14 |
CD14 |
NM_000591.2; NM_001040021.1 |
|
Hs.163867 |
CD14 molecule |
|
|
|
|
| CD163 |
CD163, M130, MM130 |
NM_004244.3; NM_203416.1 |
|
Hs.504641 |
CD163 molecule |
|
|
|
|
| CD4 |
p55 |
M35160.1 |
3 |
Hs. 17483 |
CD4 antigen (p55) |
|
|
|
|
| CD48 |
BCM1, BLAST, BLAST1 |
NM_001778.2 |
3 |
Hs.243564 |
CD48 antigen |
|
|
|
|
| CD83 |
BL11, BL11-PEN, HB15 |
NM_004233.3 |
3 |
Hs.484703 |
CD83 antigen (activated B lymphocytes, immunoglobulin superfamily) |
|
|
|
|
| CD8A |
CD8, MAL, p32 |
NM_001768.5; NM_171827.2 |
6 |
Hs.85258 |
CD8 antigen, alpha polypeptide (p32) |
|
|
|
|
| CDA |
CDA (#), CDD |
NM_001785.2 |
7 |
Hs.466910 |
cytidine deaminase |
|
|
|
|
| CDC2 |
CDK1 |
NM_001786.2 |
1 |
Hs.334562 |
cell division cycle 2, G1 to S and G2 to M |
|
|
|
|
| CDC20 |
P55CDC-LSB, p55CDC |
NM_001255.2 |
2 |
Hs.524947 |
cell division cycle 20, S.cerevisiae molog |
|
|
|
|
| CDC25C |
CDC25 |
NM_001790.3; NM_022809.2 |
3 |
Hs.656 |
cell division cycle 25C |
|
|
|
|
| CDC2L2 |
FLJ13052, CLK-1, p58/GTA, CDC2L3, PITSLRE |
M37712.1 |
7 |
Hs.467478 |
cell division cycle 2-like 2 |
|
|
|
|
| CDC42 |
CDC42Hs, G25K |
NM_001791.3 |
2 |
Hs.467637 |
cell division cycle 42 (GTP-binding protein, 25kD) |
|
|
|
|
| CDH2 |
CDHN, NCAD |
NM_001792.2 |
6 |
Hs.334131 |
cadherin 2, type 1, N-cadherin (neuronal) |
|
|
|
|
| CDH3 |
CDHP, HJMD, PCAD |
NM_001793.3 |
4 |
Hs.191842 |
cadherin 3, P-cadherin (placental) |
|
|
|
|
| CDH5 |
7B4, VE-cadherin, V-cadherin, 7B4 antigen, cd144 antigen |
NM_001795.2 |
7 |
Hs.76206 |
cadherin 5, type 2, VE-cadherin (vascular epithelium) |
|
|
|
|
| CDH6 |
CDH6 (%), KCAD, K-cadherin |
NM_004932.2 |
7 |
Hs.171054 |
cadherin 6, type 2, K-cadherin (fetal kidney) |
|
|
|
|
| CDK2 |
CDK2 |
NM_001798.2 |
7 |
Hs.19192 |
cyclin-dependent kinase 2 - TRANSCRIPT VARIANT 1 |
|
TRANSCRIPT VARIANT 2: NM_052827.1 |
|
|
| CDK2AP2 |
DOC1R, DOC-1R |
NM_005851.3 |
5 |
Hs.523835 |
deleted in oral cancer related 1 |
|
|
|
|
| CDK7 |
CAK1, CDKN7, MO15, STK1 |
NM_001799.2 |
1 |
Hs.184298 |
cyclin-dependent kinase 7 (homolog of Xenopus MO15 cdk-activating kinase) |
|
|
|
|
| CDK8 |
K35 |
NM_001260.1 |
1 |
Hs.382306 |
cyclin-dependent kinase 8 |
|
|
|
|
| CDK9 |
C-2k, CDC2L4, PITALRE, TAK |
NM_001261.2 |
3 |
Hs.150423 |
cyclin-dependent kinase 9 (CDC2-related kinase) |
|
|
|
|
| CDKN1A |
CAP20, CDKN1, CIP1, MDA6, P21, PIC1, SDI1, WAF1 |
NM_000389.2 / NM_078467.1 |
1 |
Hs.370771 |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
|
|
|
| CDKN1B |
CDKN4, KIP1, P27KIP1, P27 |
NM_004064.2 |
1 |
Hs.238990 |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
|
|
|
|
| CDKN2A |
ARF, CDK41, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, P16, p14, p16, p19 |
NM_000077.3 / NM_058197.2 / NM_058197.2 |
1 |
Hs.421349 |
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) |
|
TRANSCRIPT VARIANT 3 : NM_058197.2 |
|
|
| CDKN2C |
CDKN6, INK4C, P18 |
NM_001262.2 / NM_078626.1 |
1 |
Hs.525324 |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
|
|
|
|
| CEACAM1 |
BGP, BGP1 |
NM_001712.3 |
5 |
Hs.512682 |
carcinoembryonic antigen-related cell adhesion molecule 1 |
|
|
|
|
| CEBPD |
CEBPD (MCO), CEBPD |
NM_005195.3 |
7 |
Hs.440829 |
CCAAT/enhancer binding protein (C/EBP), delta |
|
|
|
|
| CEBPG |
|
NM_001806.2 |
13 |
|
CCAAT/enhancer binding protein (C/EBP), gamma |
|
|
|
|
| CES2 |
CE-2, hCE-2, iCE |
NM_003869.4 / NM_198061.1 |
7 |
Hs.282975 |
carboxylesterase 2 (intestine, liver) - TRANSCRIPT VARIANTS 1 AND 2 |
|
|
|
|
| CGRRF1 |
CGR19 |
NM_06568.2 |
3 |
Hs.59106 |
cell growth regulatory with ring finger domain |
|
|
|
|
| CHAF1B |
CAF-1, CAF1, CAF1A, CAF1P60, MPHOSPH7, MPP7 |
NM_005441.2 |
2 |
Hs.75238 |
chromatin assembly factor 1, subunit B |
|
|
|
|
| CIRBP |
A18HNRNP, CIRP |
NM_001280.1 |
3 |
Hs.437351 |
cold inducible RNA-binding protein |
|
|
|
|
| CKM |
CKMM |
NM_001824.2 |
4 |
Hs.334347 |
creatine kinase, muscle |
|
|
|
|
| CLCN3 |
CLC3, CIC-3 |
NM_001829.2 / NM_173872.2 |
1 |
Hs.481186 |
chloride channel 3 |
|
|
|
|
| CLU |
APOJ, CLI, SGP-2, SP-40, TRPM2 |
NM_001831.2 / NM_203339.1 |
6 |
Hs.436657 |
clusterin (complement lysis inhibitor, SP-40,40, sulfated glycoprotein 2, testosterone-repressed prostate message 2, apolipoprotein J) |
|
|
|
|
| CNN2 |
calponin 2 |
NM_004368.2 / NM_201277.1 |
3 |
Hs.169718 |
calponin 2 |
|
|
|
|
| CNR1 |
CNR |
NM_016083.3; NM_033181.2 |
3 |
Hs.75110 |
cannabinoid receptor 1 (brain) |
|
|
|
|
| CNTFR |
CNTFR |
NM_147164.1 / NM_001842.3 |
4 |
Hs.129966 |
ciliary neurotrophic factor receptor |
|
|
|
|
| COL1A2 |
HGNC:8128, OI4 |
NM_000089.3 |
3 |
Hs.489142 |
collagen, type I, alpha 2 |
|
|
|
|
| COL3A1 |
COLLAGEN 3, Coll3 |
NM_000090.3 |
1 |
Hs.443625 |
collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal dominant) |
|
|
|
|
| CORO1A |
CLIPINA, CORO1, Clabp, HCORO1, TACO, coronin-1, p57 |
NM_007074.1 |
2 |
Hs.109606 |
coronin, actin-binding protein, 1A |
|
|
|
|
| CORT |
cortistatin |
NM_001302.3 |
3 |
Hs.412311 / 512337 |
cortistatin |
|
|
|
|
| COX7C |
COX7 |
X16560.1 |
4 |
Hs.430075 |
cytochrome c oxidase subunit VIIc |
|
|
|
|
| CPB2 |
CPU, PCPB, TAFI |
NM_001872.3; NM_016413.3 |
4 |
Hs.512937 |
carboxypeptidase B2 (plasma) |
|
TRANSCRIPT VARIANT 2 : NM_016413.2 |
|
|
| CPE |
CPE |
NM_001873.1 |
5 |
Hs.75360 |
carboxypeptidase E |
|
|
|
|
| CRK |
c-CRK |
NM_016823.2 |
6 |
Hs.511822 |
v-crk sarcoma virus CT10 oncogene homolog (avian) TRANSCRIPT VARIANTS I AND II |
|
TRANSCRIPT VARIANT 1 : NM_005206.3 |
|
|
| CRSP9 |
CRSP33 |
NM_004270.3 |
3 |
Hs.279902 |
cofactor required for Sp1 transcriptional activation, subunit 9 (33kD) |
|
|
|
|
| CRYBA4 |
CRYBA4 |
NM_001886.1 |
7 |
Hs.57690 |
crystallin, beta A4 |
|
|
|
|
| CRYZ |
CRYZ |
NM_001889.2 |
6 |
Hs.83114 |
crystallin, zeta (quinone reductase) |
|
|
|
|
| CSH1 |
CSA, PL, hCS-A |
NM_001317.3 |
4 |
Hs.347963 |
chorionic somatomammotropin hormone 1 (placental lactogen) |
|
TRANSCRIPT VARIANT 2 : NM_022640.2
TRANSCRIPT VARIANT 3 : NM_022641.2 |
|
|
| CSPG2 |
Versican, DKFZp686K06110, VCAN |
NM_004385.2 |
9 |
Hs.443681 |
chondroitin sulfate proteoglycan 2 (versican) |
|
|
|
|
| CSRP1 |
CSRP, CYRP, D1S181E |
NM_004078.1 |
3 |
Hs.108080 |
cysteine and glycine-rich protein 1 |
|
|
|
|
| CTPS |
CTPS |
NM_001905.1 |
5 |
Hs.473087 |
CTP synthase |
|
|
|
|
| CTSL |
CTSL |
NM_001912.3; NM_145918.2 |
5 |
Hs.418123 |
cathepsin L |
|
|
|
|
| CUTL1 |
CDP |
M74099.1 |
4 |
Hs.438974 |
cut (Drosophila)-like 1 (CCAAT displacement protein) |
|
|
|
|
| CX3CL1 |
CX3CL1 (#), CXC3, CXC3C, FKN, NTN, NTT, SCYD1, A-152E5.2, ABCD-3, C3Xkine, CX3C |
NM_002996.3 |
7 |
Hs.531668 |
chemokine (C-X3-C motif) ligand 1 |
|
|
|
|
| CYB5R3 |
NADH, DIA1 |
NM_000398.4; NM_007326.2 |
1 |
Hs.517666 |
diaphorase (NADH) (cytochrome b-5 reductase) |
|
|
|
|
| CYP19A1 |
CYP19, ARO, ARO1, CYAR, P-450-arom, P450arom |
NM_000103.2 / NM_031226.1 |
3 |
Hs.511367 |
cytochrome P450, subfamily XIX (aromatization of androgens) |
|
|
|
|
| CYP1A1 |
AHRR, CYP1 |
NM_000499.2 |
1 |
Hs.72912 |
cytochrome P450, subfamily I (aromatic compound-inducible), polypeptide 1 |
|
|
|
|
| CYP1A2 |
CYP1A2 |
NM_000761.3 |
3 |
Hs.1361 |
cytochrome P450, subfamily I (aromatic compound-inducible), polypeptide 2 |
|
|
|
|
| CYP1B1 |
GLC3A |
NM_000104.2 |
1 |
Hs.154654 |
cytochrome P450, subfamily I (dioxin-inducible), polypeptide 1 (glaucoma 3, primary infantile) |
|
|
|
|
| CYP2A13 |
CYP2A13 |
U22028.1 |
4 |
Hs.181973 |
cytochrome P450, subfamily IIA (phenobarbital-inducible), polypeptide 13 |
|
|
|
|
| CYP2B6 |
CYP2B6 |
M29873.1 |
1 |
Hs.529117 |
cytochrome P450, subfamily IIB (phenobarbital-inducible), polypeptide 6 |
|
|
|
|
| CYP2C9 |
CYP2C10, P450IIC9 |
NM_000771.2 |
3 |
Hs.282624 |
Human cytochrome P4502C9 (CYP2C9) mRNA, clone 65 |
|
|
|
|
| CYP2D6 |
CPD6, CYP2D, CYP2D@, HGNC:2629, P450-DB1, P450C2D |
NM_000106.4 / NM_001025161.1 |
4 |
Hs.534311 |
cytochrome P450, subfamily IID |
|
|
|
|
| CYP2E1 |
CYP2E, P450C2E |
NM_000773.3 |
1 |
Hs.12907 |
cytochrome P450, subfamily IIE (ethanol-inducible) |
|
|
|
|
| CYP4B1 |
CYP4B1 |
NM_000779.2 |
2 |
Hs.687 |
cytochrome P450, subfamily IVB, polypeptide 1 |
|
|
|
|
| DAD1 |
DAD1 |
NM_001344.1 |
3 |
Hs.82890 |
defender against cell death 1 |
|
|
|
|
| DAO |
DAMOX |
NM_001917.3 |
1 |
Hs.113227 |
D-amino-acid oxidase |
|
|
|
|
| DAP |
DAP1 |
NM_004394.1 |
4 |
Hs.75189 |
death-associated protein |
|
|
|
|
| DBH |
DBH |
NM_000787.3 |
7 |
Hs.223858 |
dopamine beta-hydroxylase (dopamine beta-monooxygenase) |
|
|
|
|
| DBI |
ACBP |
NM_020548.5 |
3 |
Hs.78888 |
diazepam binding inhibitor (GABA receptor modulator, acyl-Coenzyme A binding protein) |
|
|
|
|
| DCK |
DCK |
NM_000788.1 |
7 |
Hs.709 |
deoxycytidine kinase |
|
|
|
|
| DCX |
DBCN, DC, LISX, SCLH, XLIS |
NM_000555.2 / NM_178152.1 / NM_178153.1 / NM_178151.1 |
4 |
Hs.34780 |
doublecortex; lissencephaly, X-linked (doublecortin |
|
|
|
|
| DDB2 |
DDB2 |
NM_000107.1 |
3 |
Hs.446564 |
damage-specific DNA binding protein 2 (48kD) |
|
|
|
|
| DEFA1 |
DEF1, MRS, DEFA2, HNP-1, HP-1, HP1 |
NM_004084.2 |
|
Hs.380781 |
defensin, alpha 1 |
|
|
|
|
| DEFA4 |
DEF4, HP-4, HP4 |
NM_001925.1 |
4 |
Hs.2582 |
defensin, alpha 4, corticostatin |
|
|
|
|
| DEFB1 |
BD1, HBD-1 |
NM_005218.3 |
6 |
Hs.32949 |
defensin, beta 1 |
|
|
|
|
| DNASE1 |
DNL1, DRNI |
NM_005223.3 |
1 |
Hs.436928 |
deoxyribonuclease I |
|
|
|
|
| DPP4 |
CD26, ADCP2, DPPIV |
NM_001935.3 |
5 |
Hs.368912 |
dipeptidylpeptidase IV |
|
|
|
|
| DPYD |
DPYD ($), DHP, DPD |
NM_000110.3 |
7 |
Hs.335034 |
dihydropyrimidine dehydrogenase |
|
|
|
|
| DPYS |
DHP, DHPase |
NM_001385.1 |
1 |
Hs.443161 |
dihydropyrimidinase |
|
|
|
|
| DRG2 |
DRG2 |
NM_001388.3 |
2 |
Hs.78582 |
developmentally regulated GTP-binding protein 2 |
|
|
|
|
| DSCR1 |
ADAPT78, DSC1, MCIP1 |
NM_004414.5 / NM_203417.1 / NM_203418.1 |
3 |
Hs.282326 |
Down syndrome candidate region 1 |
|
|
|
|
| DUSP6 |
PYST1,MKP3 |
NM_001946.2/NM_022652.2 |
9 |
Hs.298654 |
Dual specificity protein phosphatase 6 |
|
|
|
|
| DYNLL1 |
PIN, DLC1, DLC8, DNCLC1, HDLC1, LC8, hdlc1, DNCL1 |
NM_003746.2 |
2 |
Hs.5120 |
dynein, cytoplasmic, light polypeptide |
|
|
|
|
| E2F1 |
E2F-1, RBBP3, RBP3 |
NM_005225.1 |
1 |
Hs.96055 |
E2F transcription factor 1 |
|
|
|
|
| E2F3 |
E2F-3, KIAA0075 |
NM_001949.2 |
7 |
Hs.269408 |
E2F transcription factor 3 |
|
|
|
|
| E2F4 |
E2F-4 |
NM_001950.2 |
1 |
Hs.108371 |
E2F transcription factor 4, p107/p130-binding |
|
|
|
|
| E2F5 |
E2F-5 |
NM_001951.2 |
1 |
Hs.445758 |
E2F transcription factor 5, p130-binding |
|
|
|
|
| EBAG9 |
EB9, RCAS1 |
NM_004215.3 |
4 |
Hs.409368 |
estrogen receptor binding site associated, antigen, 9 |
|
|
|
|
| EDG1 |
D1S3362 |
NM_001400.3 |
3 |
Hs.154210 |
endothelial differentiation, sphingolipid G-protein-coupled receptor, 1 |
|
|
|
|
| EDNRA |
ETA, ETRA |
NM_001957.1 |
3 |
Hs.183713 |
endothelin receptor type A |
|
|
|
|
| EFNB1 |
EFL-3, EPLG2, Elk-L, LERK2, ephrin-B1 |
NM_004429.3 |
3 |
Hs.144700 |
ephrin-B1 |
|
|
|
|
| EGR1 |
G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225, EGR-1 |
NM_001964.2 |
2 |
Hs.326035 |
early growth response 1 |
|
|
|
|
| EIF1 |
A121, ISO1, SUI1 |
NM_005801.3 |
6 |
Hs.150580 |
putative translation initiation factor |
|
|
|
|
| EIF3S3 |
eIF3-gamma, eIF3-p40 |
NM_003756.2 |
7 |
Hs.492599 |
eukaryotic translation initiation factor 3, subunit 3 (gamma, 40kD) |
|
|
|
|
| ELAVL1 |
HUR, HuR, Hua, MelG |
NM_001419.2 |
3 |
Hs.184492 |
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R) |
|
|
|
|
| EMP2 |
XMP |
NM_001424.3 |
4 |
Hs.531561 |
epithelial membrane protein 2 |
|
|
|
|
| EMP3 |
YMP |
NM_001425.1 |
2 |
Hs.9999 |
epithelial membrane protein 3 |
|
|
|
|
| ENO2 |
NSE |
NM_001975.2 |
1 |
Hs.511915 |
enolase 2, (gamma, neuronal) |
|
|
|
|
| ENTPD5 |
CD39L4, NTPDase-5, CD39-like 4 |
NM_001249.1 |
4 |
Hs.131555 |
ectonucleoside triphosphate diphosphohydrolase 5 |
|
|
|
|
| EPHA5 |
EHK1, EphA5, HEK7, Hek7EPHAR5 |
NM_004439.4 / NM_182472.1 |
3 |
Hs.479853 |
EphA5 |
|
|
|
|
| EPHB1 |
EPHT2, Elk, EphB1, Hek6, NET |
NM_004441.3 |
2 |
Hs.116092 |
EphB1 |
|
|
|
|
| ER01L |
ER01L, EROL1 |
NM_014584.1 |
5 |
Hs.525339 |
ER01-like (S. cerevisiae) |
|
|
|
|
| ERBB2 |
HER2, HER-2, NEU, NGL |
NM_004448.2 / NM_001005862.1 |
1 |
Hs.460019 |
V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog) |
|
|
|
|
| ERCC1 |
RAD1, XFP, ERCC11 |
NM_001983.2 |
13 |
Hs.59544 |
excision repair cross-complementing rodent repair deficiency, complementation group 1 (includesoverlapping antisense sequence) |
|
|
|
|
| ERCC2 |
EM9, MAG, XPD, XPDC |
NM_000400.2 |
3 |
Hs.487294 |
excision repair cross-complementing rodent repair deficiency, complementation group 2 (xeroderma pigmentosum D) |
|
|
|
|
| ERCC4 |
ERCC11, RAD1, XPF |
NM_005236.1 |
1 |
Hs.511917 |
excision repair cross-complementing rodent repair deficiency, complementation group 4 |
|
|
|
|
| ERCC5 |
ERCM, XPG, XPGC, XPG/P135 |
NM_000123.2 |
2 |
Hs.258429 |
excision repair cross-complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome)) |
|
|
|
|
| ESR1 |
ESR1 (##), ER, ESR, ESRA, Era, NR3A1 |
NM_000125.2 |
7 |
Hs.208124 |
estrogen receptor 1 |
|
|
|
|
| ETS1 |
ETS1 |
NM_005238.2 |
6 |
Hs.369438 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 (avian) |
|
|
|
|
| EWSR1 |
EWS |
NM_005243.2; NM_013986.2 |
2 |
Hs.374477 |
Ewing sarcoma breakpoint region 1 |
|
|
|
|
| EXO1 |
HEX1, hExo1 |
NM_006027.3 / NM_130398.2 / NM_003686.3 |
2 |
Hs.498248 |
exonuclease 1 |
|
|
|
|
| F10 |
F10 |
NM_000504.3 |
4 |
Hs.361463 |
coagulation factor X |
|
|
|
|
| FABP1 |
FABPL, L-FABP |
NM_001443.1 |
4 |
Hs.380135 |
fatty acid binding protein 1, liver |
|
|
|
|
| FABP5 |
E-FABP, EFABP, PA-FABP, PAFABP |
NM_001444.1 |
3 |
Hs.408061 |
fatty acid binding protein 5 (psoriasis-associated) |
|
|
|
|
| FADD |
MORT1 |
NM_003824.2 |
6 |
Hs.86131 |
Fas (TNFRSF6)-asociated via death domain |
|
|
|
|
| FANCG |
FAG, XRCC9 |
NM_004629.1 |
5 |
Hs.434873 |
Fanconi anemia, complementation group G |
|
|
|
|
| FAP |
FAPA |
NM_004460.2 |
4 |
Hs.516493 |
fibroblast activation protein, alpha |
|
|
|
|
| FASN |
FASN ($), FAS |
NM_004104.4 |
7 |
Hs.83190 |
fatty acid synthase |
|
|
|
|
| FCGR3A |
CDC16, CDC16A, FCG3, FCGR3, IGFR3 |
J04162.1 |
4 |
Hs.372679 |
Fc fragment of IgG, low affinity IIIa, receptor for (CD16) |
|
|
|
|
| FGF10 |
FGF10 |
NM_004465.1 |
6 |
Hs.248049 |
fibroblast growth factor 10 |
|
|
|
|
| FGF12 |
FHF1, HGNC:3669 |
NM_021032.2 |
4 |
Hs.185577 |
fibroblast growth factor 12 |
|
|
|
|
| FGF17 |
FGF-13 |
NM_003867.2 |
4 |
Hs.248192 |
fibroblast growth factor 17 |
|
|
|
|
| FGF9 |
FGF9 |
NM_002010.1 |
2 |
Hs.111 |
fibroblast growth factor 9 (glia-activating factor) |
|
|
|
|
| FGL2 |
FGL2 |
NM_006682.2 |
7 |
Hs.520989 |
fibrinogen-like 2 |
|
|
|
|
| FKBP4 |
FKBP52, FKBP59 |
NM_002014.2 |
7 |
Hs.524183 |
FK506 binding protein 4 (59kDa) |
|
|
|
|
| FN1 |
FN, FIBRONECTIN |
NM_212482.1 / NM_002026.2 / NM_212476.1 |
1 |
Hs.203717 |
fibronectin 1 |
|
|
|
|
| FOLH1 |
FOLH, NAALAD1, PSM, PSMA |
NM_004476.1 |
4 |
Hs.380325 |
folate hydrolase (prostate-specific membrane antigen) 1 |
|
|
|
|
| FOS |
G0S7, C-FOS |
NM_005252.2 |
2 |
Hs.25647 |
v-fos FBJ murine osteosarcoma viral oncogene homolog |
|
|
|
|
| FOSL1 |
FOSL, FRA-1, FRA1 |
NM_005438.2 |
1 |
Hs.283565 |
FOS-like antigen-1 |
|
|
|
|
| FOSL2 |
FRA2 |
NM_005253.1 |
4 |
Hs.301612 |
FOS-like antigen 2 |
|
|
|
|
| FOXA1 |
HNF3A, FAXA1, TCF3A, HNF3 alpha |
NM_0004496.2 |
1 |
Hs.163484 |
hepatocyte nuclear factor 3, alpha |
|
|
|
|
| FOXA2 |
HNF3B, FOXA2, TCF3B, HNF3 beta |
NM_021784.3 / NM_153675.1 |
2 |
Hs.155651 |
hepatocyte nuclear factor 3, beta |
|
|
|
|
| FOXJ1 |
FKHL13, HFH-4, HFH4 |
NM_001454.2 |
2 |
Hs.370041 |
forkhead box J1 |
|
|
|
|
| FOXM1 |
FOXM1B, FKHL16, HFH-11, HFH11, HNF-3, INS-1, MPHOSPH2, MPP-2, TRIDENT, WIN |
NM_202002.1 / NM_021953.2 / NM_202003.1 |
7 |
Hs.511941 |
forkhead box M1 - TRANSCRIPT VARIANTS 1, 2 AND 3 |
|
|
|
|
| FPGS |
FPGS |
NM_004957.4 / NM_001018078.1 |
1 |
Hs.335084 |
folylpolyglutamate synthase |
|
|
|
|
| FRAP1 |
FRAP, FRAP2, MTOR, RAFT1 |
NM_004958.2 |
4 |
Hs.338207 |
FK506 binding protein 12-rapamycin associated protein 1 |
|
|
|
|
| FRZB |
FRE, FRP-3, FRZB-PEN, FRZB1, Fritz, Frzb-1, SFRP3, fre, frzb, hfiz |
NM_001463.2 |
3 |
Hs.128453 |
frizzled-related protein |
|
|
|
|
| FURIN |
FUR, PCSK3, SPC1, PACE, PACE-1. |
NM_002569.2 |
6 |
Hs.513153 |
paired basic amino acid cleaving enzyme (furin, membrane associated receptor) |
|
|
|
|
| FUT3 |
FT3B, LE |
NM_000149.1 |
6 |
Hs.169238 |
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase) |
|
|
|
|
| FZD10 |
FZD10 |
NM_007197.2 |
7 |
Hs.31664 |
frizzled homolog 10 (Drasophila) |
|
|
|
|
| FZD9 |
FZD3, FZD3-PEN |
NM_003508.2 |
3 |
Hs.534367 |
frizzled (Drosophilia) homolog 9 |
|
|
|
|
| G6PD |
G6PD1 |
NM_000402.3 |
6 /14 |
Hs.461047 |
glucose-6-phosphate dehydrogenase |
|
|
|
|
| GAK |
GAK |
NM_005255.1 |
6 |
Hs.369607 |
cyclin G associated kinase |
|
|
|
|
| GAPDH |
G3PDH, GAPD, GAPDH2 |
NM_002046.2 |
1 |
Hs.169476 |
glyceraldehyde-3-phosphate dehydrogenase |
|
|
|
|
| GATA3 |
HDR, MGC5445 |
NM_001002295.1 / NM_002051.2 |
7 |
Hs.524134 |
GATA binding protein 3 - TRANSCRIPT VARIANTS 1 AND 2 |
|
|
|
|
| GCLC |
GCS, GLCL, GLCLC |
NM_001498.2 |
1 |
Hs.271264 |
glutamate-cysteine ligase (gamma-glutamylcysteine synthetase), catalytic(72.8kD) |
|
|
|
|
| GFAP |
GFAP |
NM_002055.2 |
7 |
Hs.514227 |
glial fibrillary acidic protein |
|
|
|
|
| GGH |
hGH, GH, FPGH |
NM_003878.1 |
1 |
Hs.78619 |
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) |
|
|
|
|
| GJA1 |
CX43, CGJP, DFNB38 |
NM_000165.3 |
1 |
Hs.74471 |
gap junction protein, alpha 1, 43kD (connexin 43) |
|
|
|
|
| GJB1 |
CMTX, CMTX1, CX32 |
NM_000166.2 |
5 |
Hs.333303 |
gap junction protein, beta 1, 32kDa (connexin 32, Charcot-Marie-Tooth neuropathy, X-linked) |
|
|
|
|
| GLI2 |
THPO |
NM_005270.3 |
1 |
Hs.111867 |
GLI-Kruppel family member GLI2 |
|
|
|
|
| GLI3 |
GCPS, PAP-A, PAPA, PAPB, PHS |
NM_000168.3 |
3 |
Hs.199338 |
GLI-Kruppel family member GLI3 (Greig cephalopolysyndactyly syndrome) |
|
|
|
|
| GLYAT |
GAT |
NM_005836.3 |
5 |
Hs.145384 |
glycine-N-acyltransferase |
|
|
|
|
| GMFG |
GMF-GAMMA |
NM_004877.1 |
3 |
Hs. 5210 |
glia maturation factor, gamma |
|
|
|
|
| GNAZ |
GNAZ |
NM_002073.2 |
6 |
Hs.526920 |
guanine nucleotide binding protein (G protein), alpha z polypeptide |
|
|
|
|
| GNLY |
519, D2S69E, LAG-2, LAG2, NKG5, TLA519GNLY |
NM_012483.1 / NM_006433.2 |
2 |
Hs.105806 |
granulysin |
|
|
|
|
| GPM6A |
GPM6, M6A |
NM_005277.3 / NM_201591.1 / NM_201592.1 |
3 |
Hs.75819 |
glycoprotein M6A |
|
|
|
|
| GPT |
AAT1, ALT1, GPT1 |
NM_005309.1 |
6 |
Hs.103502 |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
|
|
|
| GPX1 |
GSHPx |
NM_000581.2 |
5 |
Hs.76686 |
glutathione peroxidase 1 |
|
|
|
|
| GPX3 |
GPXP, GSHPX A |
NM_002084.2 |
1 |
Hs.386793 |
glutathione peroxidase 3 (plasma) |
|
|
|
|
| GRB7 |
GRB7 (#), GRB7 |
NM_005310.2 |
7 |
Hs.86859 |
growth factor receptor-bound protein 7 |
|
|
|
|
| GSR |
GLUR, GRD1 |
NM_000637.2 |
1 |
Hs.271510 |
glutathione reductase |
|
|
|
|
| GSS |
GSHS, GSYN |
NM_000178.2 |
2 |
Hs.82327 |
glutathione synthetase |
|
|
|
|
| GSTA1 |
GSTA1 (%), GST-epsilon, GST2, GSTA-1, GTH1, H-A |
NM_145740.2 |
7 |
Hs.446309 |
glutathione S-transferase A1 |
|
|
|
|
| GSTM1 |
GST1, H-B, MU, GSTM1,2,4,5 |
NM_000561.2 / NM_146421.1 |
1 |
Hs.301961 |
glutathione S-transferase M1/M2/M4/M5 |
| Previously Labels as GSTM1,2,4,5 |
|
|
|
| GSTM3 |
GST5 |
NM_00849.3 |
1 |
Hs.2006 |
glutathione S-transferase M3 (brain) |
|
|
|
|
| GSTP1 |
FAEES3, GST3, PI |
NM_000852.2 |
1 |
Hs.523836 |
glutathione S-transferase pi |
|
|
|
|
| GSTT1 |
GSTT1 |
NM_000853.1 |
1 |
Hs.268573 |
glutathione S-transferase theta 1 |
|
|
|
|
| GSTZ1 |
GSTZ1-1, MAAI, MAI |
NM_001513.2 |
3 |
Hs.26403 |
glutathione S-transferase zeta 1 (maleylacetoacetate isomerase) |
|
TRANSCRIPT VARIANT 1: NM_145870.1
TRANSCRIPT VARIANT 2: NM_145871.1 |
|
|
| GTF2H2 |
p44, BTF2, BTH2P44, TFIIH |
NM_001515.3 |
5 |
Hs.191356 |
general transcription factor IIH, polypeptide 2 (44kD subunit) |
|
|
|
|
| GUSB |
Beta-G1, FLJ39445, MPS7 |
NM_000181.2 |
14 |
Hs.255230 |
glucuronidase, beta |
|
|
|
|
| HINT1 |
PKCI-1, PRKCNH1 |
NM_005340.3 |
2 |
Hs.160562 |
histidine triad nucleotide-binding protein |
|
|
|
|
| HK3 |
HK3 |
NM_002115.1 |
5 |
Hs.411695 |
hexokinase 3 (white cell) |
|
|
|
|
| HLA-DPA1 |
HLA-DP1A |
NM_033554.2 |
6 |
Hs.347270 |
major histocompatibility complex, class II, DP alpha 1 |
|
|
|
|
| HLA-DPB1 |
HLA-DP1B |
NM_002121.4 |
4 |
Hs.485130 |
major histocompatibility complex, class II, DP beta 1 |
|
|
|
|
| HLA-DQA1 |
HLA-DQA1 |
NM_002122.3 |
6 |
Hs.387679 |
major histocompatibility complex, class II, DQ alpha 1 |
|
|
|
|
| HLA-DRA |
HLA-DRA |
NM_019111.3 |
6 |
Hs.520048 |
major histocompatibility complex, class II, DR alpha |
|
|
|
|
| HLA-DRB5 |
HLA-DRB5 |
M20430.2 |
6 |
Hs.520049 |
major histocompability complex, class II, DR beta 5 |
|
|
|
|
| HMBS |
HMBS (#), AIP, PBGD, UPS |
NM_000190.3 |
7 |
Hs.82609 |
hydroxymethylbilane synthase |
|
|
|
|
| HNMT |
HNMT |
NM_006895.2 |
4 |
Hs.42151 |
histamine N-methyltransferase |
|
|
|
|
| HNRPA3 |
D10S102, FBRNP |
NM_194247.2 |
4 |
Hs.516539 |
heterogeneous nuclear protein similar to rat helix destabilizing protein |
|
|
|
|
| HPN |
TMPRSS1 |
NM_002151.1 |
3 |
Hs.182385 |
hepsin (transmembrane protease, serine 1) |
|
|
|
|
| HRASLS |
A-C1, H-REV107 |
NM_020386.2 |
6 |
Hs.36761 |
HRAS-like suppressor |
|
|
|
|
| HRB |
RAB, RIP |
NM_004504.3 |
7 |
Hs.443507 |
HIV-1 Rev-binding protein |
|
|
|
|
| HSD11B1 |
11HSD1, HSD11, HSD11B, HSD11L |
NM_005525.2 / NM_181755.1 |
1 |
Hs.195040 |
hydroxysteroid (11-beta) dehydrogenase 1 |
|
|
|
|
| HSD11B2 |
HSD11K |
NM_000196.3 |
3 |
Hs.1376 |
hydroxysteroid (11-beta) dehydrogenase 2 |
|
|
|
|
| HSP90AA1 |
HSP90A, HSPC1, HSPCA |
NM_005348.2 |
7 |
Hs.525600 |
heat shock 90kD protein 1, alpha |
|
|
|
|
| HSPA2 |
HSPA2 |
L26336.1 |
7 |
Hs.432648 |
heat shock 70kD protein 2 |
|
|
|
|
| HSPA9B |
GRP75, HSPA9, MOT2, PBP74, mot-2, mthsp75, HSP75 |
NM_004134.4 |
1 |
Hs.184233 |
heat shock 70kD protein 9B (mortalin-2) |
|
|
|
|
| HSPD1 |
GROAL, HSP60 |
NM_002156.4 |
1 |
Hs.471014 |
heat shock 60kD protein 1 (chaperonin) |
|
|
|
|
| ICA1 |
ICA69, ICAp69 |
NM_022307.2; NM_004968.2 |
5 |
Hs.487561 |
islet cell autoantigen 1 (69kD) |
|
|
|
|
| ICAM1 |
BB2, CD54, ICAM-1, Icam1 |
NM_000201.1 |
1 |
Hs.515126 |
intercellular adhesion molecule 1 (CD54), human rhinovirus receptor |
|
|
|
|
| ID2 |
ID2 |
M97796.1 |
7 |
Hs.180919 |
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
|
|
|
|
| IER3 |
DIF-2, DIF2, GLY96, IEX-1, IEX-1L, IEX1, PRG1 |
NM_003897.3 |
5 |
Hs.76095 |
immediate early response 3 |
|
|
|
|
| IFIT1 |
G10P1, GARG-16, IFI-56, IFI56, IFNAI1, RNM561 |
NM_001548.3 |
7 |
Hs.20315 |
interferon-induced protein with tetratricopeptide repeats 1 - TRANSCRIPT VARIANT 1 |
|
|
|
|
| IFNAR2 |
IFNABR, IFNARB |
NM_207585.1 |
5 |
Hs.512211 |
interferon (alpha, beta, and omega) receptor 2 |
|
|
|
|
| IFNG |
IFNG |
NM_000619.2 |
2 |
Hs.856 |
interferon, gamma |
|
|
|
|
| IFRD1 |
PC4 |
NM_001550.2 / NM_001007245.1 |
5 |
Hs.7879 |
interferon-related developmental regulator 1 |
|
|
|
|
| IGF1 |
IBP1 |
NM_000618.2 |
2 |
Hs.308053 |
insulin-like growth factor 1 (somatomedin C) |
|
|
|
|
| IGF2R |
MPRI |
NM_000876.2 |
4 |
Hs.487062 |
insulin-like growth factor 2 receptor |
|
|
|
|
| IGFBP2 |
BP2, IBP2 |
NM_000597.2 |
5 |
Hs.438102 |
insulin-like growth factor binding protein 2 (36kD) |
|
|
|
|
| IGFBP3 |
IGFBP3, IBP3 |
NM_001013398.1 / NM_000598.4 |
7 |
Hs.450230 |
insulin-like growth factor binding protein 3 |
|
|
|
|
| IGFBP5 |
IGFBP5 |
NM_000599.2 |
6 |
Hs.369982 |
insulin-like growth factor binding protein 5 |
|
|
|
|
| IGLJ3 |
IGL@, IGL, IGL locus |
BC033102.1 |
4 |
Hs.449585 |
immunoglobulin lambda locus |
|
|
|
|
| IHPK1 |
KIAA0263, IP6K1 2, MGC9925, PiUS 2 |
NM_153273.3 / NM_001006115.2 |
6 |
Hs.517970 |
inositol hexaphosphate kinase 1 |
|
|
|
|
| IL1B |
IL1 beta |
NM_000576.2 |
2 |
Hs.126256 |
interleukin 1, beta |
|
|
|
|
| IL2 |
IL-2,TCGF |
NM_000586.3 |
9 |
Hs.89679 |
Interleukin 2 |
|
|
|
|
| IL6 |
BSF2, IFNB2,HGF,HSF |
NM_000600.1 |
9 |
HS.512234 |
interleukin 6 (interferon, beta 2) |
|
|
|
|
| IL8 |
LECT, LUCT, MDNCF, SCYB8, TSG-1 |
NM_000584.2 |
4 |
Hs.624 |
interleukin 8 |
|
|
|
|
| ILK |
ILK1 |
NM_004517.2 / NM_001014794.1 / NM_001014795.1 |
3 |
Hs.5158 |
integrin-linked kinase |
|
|
|
|
| INPPL1 |
SHIP2 |
NM_001567.2 |
2 |
Hs.523875 |
inositol polyphosphate phosphatase-like 1 |
|
|
|
|
| ITGA9 |
ITGA4L, RLC |
NM_002207.2 |
6 |
Hs.113157 |
integrin, alpha 9 |
|
|
|
|
| ITGAM |
CD11B, CD11b, CR3A, MAC-1, MAC1A, MGC117044, MO1A |
NM_000632.3 |
11 |
Hs.172631 |
integrin, alpha M (complement component 3 receptor 3 subunit) |
|
|
|
|
| IVL |
INVOLUCRIN |
NM_005547.2 |
1 |
Hs.516439 |
involucrin |
|
|
|
|
| JAK1 |
Jak1a, Jak1b |
NM_002227.2 |
14 |
Hs.207538 |
Janus kinase 1 (a protein tyrosine kinase) |
|
|
|
|
| JAK2 |
Jak-2 |
NM_004972.2 |
14 |
Hs.656213 |
Janus kinase 2 (a protein tyrosine kinase) |
|
|
|
|
| JAK3 |
jak-3 |
NM_000215.2 |
14 |
Hs.515247 |
Janus kinase 3 (a protein tyrosine kinase) |
|
|
|
|
| JUN |
CJUN |
NM_002228.3 |
1 |
Hs.525704 |
v-jun avian sarcoma virus 17 oncogene homolog |
|
|
|
|
| JUNB |
JUN B |
NM_002229.2 |
1 |
Hs.25292 |
jun B proto-oncogene |
|
|
|
|
| KCNK1 |
DPK, HOHO1, KCNO1, TWIK-1, TWIK1 |
NM_002245.2 |
4 |
Hs.208544 |
potassium channel, subfamily K, member 1 (TWIK-1) |
|
|
|
|
| KCNS3 |
KV9.3, Kv9.3 |
NM_002252.3 |
4 |
Hs.414489 |
potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3 |
|
|
|
|
| KDR |
FLK1, VEGFR2, KDR/flk1 |
NM_002253.1 |
2 |
Hs.479756 |
kinase insert domain receptor (a type III receptor tyrosine kinase) |
|
|
|
|
| KHDRBS1 |
P62, SAM68 |
NM_006559.1 |
1 |
Hs.445893 |
GAP-associated tyrosine phosphoprotein p62 (Sam68) |
|
|
|
|
| KIAA0020 |
KIAA0020 |
NM_014878.4 |
6 |
Hs.493309 |
KIAA0020 protein |
| Not approved by the HUGO/GDB Nomenclature Committee |
|
|
|
| KIAA0317 |
KIAA0317 |
AB002315.1 |
6 |
Hs.200628 |
KIAA0317 protein |
| Not approved by the HUGO/GDB Nomenclature Committee |
|
|
|
| KIAA1442 |
KIAA1442 |
BC054347.1 |
6 |
Hs.471955 |
KIAA1442 protein |
| Not approved by the HUGO/GDB Nomenclature Committee |
|
|
|
| KIAA1750 |
KIAA1750 |
AB051537 / AL080059 |
5 |
Hs.173094 |
KIAA1750 protein |
| Not approved by the HUGO/GDB Nomenclature Committee March 27, 2003 |
|
|
|
| KIT |
PBT |
NM_000222.1 |
5 |
Hs.479754 |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
|
|
|
| KLF10 |
EGRA, KLF10, TIEG, TIEG1 |
NM_005655.1 |
7 |
Hs.435001 |
Kruppel-like factor 10 |
|
|
|
|
| KLK11 |
PRSS20, TLSP |
NM_006853.2 / NM_144947.1 |
5 |
Hs.57771 |
kallikrein 11 |
|
|
|
|
| KLK3 |
PSA |
NM_001648.2 |
6 |
Hs.171995 |
kallikrein 3 (prostate-specific antigen) - TRANSCRIPT VARIANT 1 |
|
|
|
|
| KLK4 |
EMSP, PSTS |
NM_004917.3 |
7 |
Hs.218366 |
kallikrein 4 (prostase, enamel matrix, prostate) |
|
|
|
|
| KRT17 |
KRT17 (#), K17, PC, PC2, PCHC1 |
NM_000422.1 |
7 |
Hs.2785 |
keratin 17 |
|
|
|
|
| KRT18 |
KERATIN 18 |
NM_000224.2 / NM_199187.1 |
6 |
Hs.406013 |
karatin 18 |
|
|
|
|
| KRT5 |
EBS2, KERATIN 5 |
NM_000424.3 |
1 |
Hs.433845 |
keratin 5 (epidermolysis bullosa simplex, Dowling-Meara/Kobner/Weber-Cockayne types) |
|
|
|
|
| LAIR1 |
LAIR-1 |
NM_002287.3; NM_021706.2 |
4 |
Hs.467288 |
leukocyte-associated Ig-like receptor 1 |
|
TRANSCRIPT VARIANT b: NM_021706.1
TRANSCRIPT VARIANT d: NM_021708.1 |
|
|
| LAMB1 |
LAMIN B1 |
NM_002291.1 |
5 |
Hs.489646 |
laminin, beta 1 |
|
|
|
|
| LCN2 |
HNL, NGAL |
NM_005564.3 |
4 |
Hs.204238 |
lipocalin 2 (oncogene 24p3) |
|
|
|
|
| LCP1 |
PLS2 |
NM_002298.2 |
4 |
Hs.381099 |
lymphocyte cytosolic protein 1 (L-plastin |
|
|
|
|
| LDLR |
FH, FHC |
NM_000527.2 |
6 |
Hs.213289 |
low density lipoprotein receptor (familial hypercholesterolemia) |
|
|
|
|
| LGALS1 |
GBP |
NM_002305.3 |
2 |
Hs.445351 |
lectin, galactoside-binding, soluble, 1 (galectin 1) |
|
|
|
|
| LGALS9 |
LGALS9 |
NM_009587.2 |
5 |
Hs.81337 |
lectin, galactoside-binding, soluble, 9 (galectin 9)- TRANSCRIPT VARIANT LONG |
|
|
|
|
| LIG1 |
LIG1 |
NM_000234.1 |
5 |
Hs.1770 |
ligase I, DNA, ATP-dependent |
|
|
|
|
| LIG4 |
LIG4 |
NM_002312.3 / NM_206937.1 |
4 |
Hs.166091 |
ligase IV, DNA, ATP-dependent |
|
|
|
|
| LIMK1 |
LIMK |
NM_002314.2 |
4 |
Hs.36566 |
LIM domain kinase 1 |
|
|
|
|
| LOX |
LOX |
NM_002317.3 |
6 |
Hs.102267 |
lysyl oxidase |
|
|
|
|
| LPPR2 |
LPPR2#, Homo sapiens cDNA: FLJ21819 fis, clone HEP01185 |
BC038439.1 |
11 |
|
lipid phosphate phosphatase-related protein type 2 |
|
|
|
|
| LTB4DH |
LTB4-12H, LTB4HD |
D49387.1 |
5 |
Hs.494804 |
NADP dependent leukotriene B4 12-hydroxydehydrogenase |
|
|
|
|
| LYN |
JYK8 |
NM_002350.1 |
4 |
Hs.491767 |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
|
|
|
| MAL |
MAL |
NM_002371.2 / NM_022439.1 |
4 |
Hs. 80395 |
mal, T-cell differentiation protein |
|
|
|
|
| MALL |
BENE, MAL |
NM_005434.3 |
6 |
Hs.185055 |
mal, T-cell differentiation protein-like |
|
|
|
|
| MAP2K1 |
MAPKK1, MEK1, MKK1, PRKMK1 |
NM_002755.2 |
5 |
Hs.145442 |
mitogen-activated protein kinase kinase 1 |
|
|
|
|
| MAP2K5 |
MAP2K5 |
NM_145160.1; NM_002757.2 |
7 |
Hs.114198 |
mitogen-activated protein kinase kinase 5 - TRANSCRIPT VARIANTS A, B, AND C |
|
|
|
|
| MAP2K6 |
MEK6, MKK6, PRKMK6, SAPKK3 |
NM_002758.3 |
2 |
Hs.463978 |
mitogen-activated protein kinase kinase 6 |
|
|
|
|
| MAP3K14 |
FTDCR1B, HS, HSNIK, NIK, hsNIK |
NM_003954.2 |
2 |
Hs.404183 |
serine/threonine protein kinase |
|
|
|
|
| MAP4K1 |
HPK1 |
NM_007181.4 |
7 |
Hs.95424 |
mitogen-activated protein kinase kinase kinase kinase 1 |
|
|
|
|
| MAP4K2 |
BL44, GCK, RAB8IP |
NM_004579.2 |
6 |
Hs.534341 |
mitogen-activating protein kinase kinase kinase kinase 2 |
|
|
|
|
| MAP4K5 |
KHS1, GCKR, MAPKKKK5 |
NM_006575.3 / NM_198794.1 |
7 |
Hs.130491 |
mitogen-activated protein kinase kinase kinase kinase 5 - TRANSCRIPT VARIANT 1 AND 2 |
|
|
|
|
| MAPK12 |
ERK3, ERK6, PRKM12, SAPK-3, SAPK3, SAPK 3, p38gamma |
Y10487.1 |
2 |
Hs.432642 |
mitogen-activated protein kinase 12 |
|
|
|
|
| MAPK7 |
BMK1, ERK4,ERK5, PRKM7 |
NM_139033.1 / NM_002749.2 / NM_139034.1 |
6 |
Hs.150136 |
mitogen-activated protein kinase 7 - TRANSCRIPT VARIANTS 1, 3, AND 4 |
|
|
|
|
| MAPK8 |
JNK, JNK1, PRKM8, SAPK1 |
NM_139049.1 / NM_002750.2 |
2 |
Hs.522924 |
mitogen-activated protein kinase 8 |
|
|
|
|
| MAPK9 |
JNK2, PRKM9, p54aSAPK |
NM_139069.1 / NM_139070.1 |
4 |
Hs.484371 |
mitogen-activated protein kinase 9 |
|
|
|
|
| MARCH6 |
KIAA0597, TEB4, C3HC4 |
NM_005885.2 |
4 |
Hs.432862 |
similar to S. cerevisiae SSM4 |
|
|
|
|
| MBP |
MBP |
NM_002385.2 |
5 |
Hs.501262 |
myelin basic protein |
|
|
|
|
| MEF2C |
MEF2C |
NM_002397.2 |
9 |
Hs.444409 |
MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C) |
|
|
|
|
| MFGE8 |
BA46, EDIL1 |
NM_005928.1 |
2 |
Hs.3745 |
milk fat globule-EGF factor 8 protein |
|
|
|
|
| MGST1 |
GST12, MGST, MGST-I |
NM_020300.3 / NM_145764.1 / NM_145791.1 / NM_145792.1 |
4 |
Hs.389700 |
microsomal glutathione S-transferase 1 |
|
|
|
|
| MKNK1 |
MNK1 |
NM_003684.3 |
5 |
Hs.371594 |
MAPP kinase-interacting serine/threonine kinase 1 |
|
|
|
|
| MLANA |
MART1, lelan-A |
NM_005511.1 |
4 |
Hs.154069 |
melan-A |
|
|
|
|
| MLH1 |
COCA2, HNPCC, HNPCC2 |
NM_000249.2 |
1 |
Hs.195364 |
mutL (E. coli) homolog 1 (colon cancer, nonpolyposis type 2) |
|
|
|
|
| MMD |
MMA |
NM_012329.2 |
4 |
Hs.463483 |
monocyte to macrophage differentiation-associated |
|
|
|
|
| MMP16 |
MMPX2, MT3-MMP |
NM_005941.2 / NM_022564.1 |
3 |
Hs.492187 |
matrix metalloproteinase 16 (membrane-inserted |
|
|
|
|
| MPG |
AAG, ANPG, MDG, MID1 |
NM_002434.2 / NM_001015052.1 / NM_001015054.1 |
2 |
Hs.459596 |
N-methylpurine-DNA glycosylase |
|
|
|
|
| MSH2 |
BAT26, COCA1, FCC1, HVPCC, HNPCC1, BAT-26 microsatellite, MSH2 |
NM_000251.1 |
1 |
Hs.156519 |
mutS (E. coli) homolog 2 (colon cancer, nonpolyposis type 1) |
|
|
|
|
| MSH6 |
GTBP, HNPCC5 |
NM_000179.1 |
1 |
Hs.445052 |
mutS (E. coli) homolog 6 |
|
|
|
|
| MT2A |
CES1, MT2 |
NM_005953.2 |
3 |
Hs.418241 |
metallothionein 2A |
|
|
|
|
| MTMR4 |
KIAA0647 |
NM_004687.3 |
6 |
Hs.514373 |
myotubularin related protein 4 |
|
|
|
|
| MUC1 |
PUM |
NM_002456.4 |
1 |
Hs.89603 |
mucin 1, transmembrane |
|
|
|
|
| MUC2 |
SMUC |
NM_002457.2 |
2 |
Hs.315 |
mucin 2, intestinal/tracheal |
|
|
|
|
| MUTYH |
MUTYH |
NM_012222.2 |
7 |
Hs.271353 |
mutY (E. coli) homolog |
|
|
|
|
| MVP |
LRP, VAULT1 |
NM_017458.2 / NM_005115.3 |
2 |
Hs.513488 |
lung resistance-related protein |
|
|
|
|
| MX2 |
MX2 |
NM_002463.1 |
3 |
Hs.926 |
myxovirus (influenza) resistance 2, homolog of murin |
|
|
|
|
| MXD1 |
MAD |
NM_002357.2 |
1 |
Hs.468908 |
MAX dimerization protein |
|
|
|
|
| MYC |
C-MYC |
NM_002467.3 |
1 |
Hs.202453 |
v-myc avian myelocytomatosis viral oncogene homolog |
|
|
|
|
| MYCBP |
AMY-1, AMY1 |
NM_012333.3 |
2 |
Hs.370040 |
c-myc binding protein |
|
|
|
|
| MYCL1 |
LMYC, MYCL |
NM_005376.3 |
7 |
Hs.437922 |
v-myc myelocytomatosis viral oncogene homolog 1, lung carcinoma derived |
|
|
|
|
| MYL2 |
MYL2 |
NM_000432.2 |
4 |
Hs.75535 |
myosin, light polypeptide 2, regulatory, cardiac, slow |
|
|
|
|
| NAPA |
ALPHASNAP, SNAPA |
NM_003827.2 |
4 |
Hs.126938 |
N-ethylmaleimide-sensitive factor attachment protein, alpha |
|
|
|
|
| NAT1 |
NAT1 ($), AAC1 |
NM_000662.4 |
7 |
Hs.155956 |
N-acetyltransferase 1 (arylamine N-acetyltransferase) |
|
|
|
|
| NCKAP1L |
HEM1 |
NM_005337.3 |
4 |
Hs.182014 |
hematopoietic protein 1 |
|
|
|
|
| NDUFB7 |
B18 |
NM_004146.4 |
3 |
Hs.532853 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7 (18kD, B18) |
|
|
|
|
| NFE2 |
NF-E2 |
NM_006163.1 |
2 |
Hs.75643 |
nuclear factor erythroid-derived 2), 45kD |
|
|
|
|
| NFIL3 |
E4BP4, IL3BP1, NF-IL3A, NFIL3A |
NM_005384.2 |
5 |
Hs.79334 |
nuclear factor, interleukin 3 regulated |
|
|
|
|
| NFKB1 |
KBF1 |
NM_003998.2 |
2 |
Hs.431926 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105) |
|
|
|
|
| NFKBIL1 |
IKBL, NFKBIL1 |
NM_005007.2 |
6 |
Hs. 2764 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1 |
|
|
|
|
| NINJ1 |
NIN1 |
NM_004148.2 |
5 |
Hs.494457 |
ninjurin 1; nerve injury-induced protein-1 |
|
|
|
|
| NKX3-1 |
NKX3.1, NKX3A |
NM_006167.2 |
6 |
Hs.55999 |
NKX3-1 (NK3 transcription factor related, locus 1 (Drosophilia)) |
|
|
No Unigene Cluster Found; Sep 23, 2002 |
|
| NME3 |
DR-nm23 |
NM_002513.2 |
2 |
Hs.81687 |
non-metastatic cells 3, protein expressed in |
|
|
|
|
| NMI |
NMI |
NM_004688.1 |
5 |
Hs.54483 |
N-myc (and STAT) interactor |
|
|
|
|
| NMU |
NMU-25 |
NM_006681.1 |
6 |
Hs.418367 |
neuromedin U |
|
|
|
|
| NNMT |
NNMT |
NM_006169.2 |
2 |
Hs.503911 |
nicotinamide N-methyltransferase |
|
|
|
|
| NPM3 |
NPM3 |
NM_006993.1 |
6 |
Hs.90691 |
nucleophosmin / nucleoplasmin, 3 |
|
|
|
|
| NPY |
NPY |
NM_000905.2 |
4 |
Hs.1832 |
neuropeptide Y |
|
|
|
|
| NQO1 |
NQO1 (%), DHQU, DIA4, DTD, QR1 |
NM_000903.2 |
7 |
Hs.406515 |
NAD(P)H dehydrogenase, quinone 1 |
|
|
|
|
| NTRK3 |
TRKC |
NM_001012338.1 / NM_002530.2 / NM_001007156.1 |
2 |
Hs.26776 |
neurotrophic tyrosine kinase, receptor, type 3 |
|
|
|
|
| NUSAP1 |
ANKT, BM037, FLJ13421, LNP, NuSAP1, PRO03110p1, Q0310, SAPL |
NM_016359.2 / NM_018454.5 |
5 |
Hs.511093 |
nucleolar and spindle associated protein 1 |
|
|
|
|
| OAZ2 |
OAZ2 |
NM_002537.1 |
5 |
Hs.74563 |
ornithine decarboxylase antizyme 2 |
|
|
|
|
| ODC1 |
ODC1 |
NM_002539.1 |
5 |
Hs.467701 |
ornithine decarboxylase 1 |
|
|
|
|
| ORC6L |
ORC6 |
NM_014321.2 |
7 |
Hs.49760 |
origin recognition complex, subunit 6-like (yeast) |
|
|
|
|
| OXCT1 |
SCOT, OXCT |
NM_000436.3 |
6 |
Hs.278277 |
3-oxoacid CoA transferase |
|
|
|
|
| PA2G4 |
PA2G4 |
NM_006191.2 |
4 |
Hs.524498 |
proliferation-associated 2G4, 38kD |
|
|
|
|
| PADI4 |
PAD, PADI5,PDI4,PDI5 |
NM_012387.1 |
9 |
Hs.522969 |
Peptidyl arginine deiminase, type IV |
|
|
|
|
| PAEP |
PEP, PP14 |
NM_002571.2 |
5 |
Hs.532325 |
progestagen-associated endometrial protein |
|
|
|
|
| PAFAH1B1 |
LIS1, MDCR, PAFAH, PAFAHA |
NM_000430.2 |
4 |
Hs. 77318 |
platelet-activating factor acetylhydrolase, isoform Ib, alpha subunit (45kD) |
|
|
|
|
| PAFAH1B2 |
PAFAHB |
D63390.1 |
4 |
Hs.188501 |
platelet-activating factor acetylhydrolase, isoform Ib, beta subunit (30kD) |
|
|
|
|
| PAK1 |
PAK1 |
NM_002576.3 |
2 |
Hs.435714 |
p21/Cdc42/Rac1-activated kinase 1 (yeast Ste20-related) |
|
|
|
|
| PCNA |
PCNA |
NM_002592.2/ NM_182649.1 |
1 |
Hs.147433 |
proliferating cell nuclear antigen |
|
|
|
|
| PCSK1 |
NEC1, PC-1, PC1, PC3, SPC3 |
NM_000439.3 |
2 |
Hs.789977 |
proprotein convertase subtilisin/kexin type 1 |
|
|
|
|
| PCTK1 |
1, PCTGAIRE |
NM_006201.3; NM_033018.2 |
2 |
Hs.171834 |
PCTAIRE protein kinase 1 |
|
|
|
|
| PCTK2 |
PCTK2 |
NM_002595.2 |
4 |
Hs.506415 |
PCTAIRE protein kinase 2 |
|
|
|
|
| PDCD10 |
TFAR15 |
NM_007217.3 / NM_145859.1 / NM_145860.1 |
4 |
Hs.478150 |
programmed cell death 10 |
|
|
|
|
| PDE7A |
HCP1 |
AF332652 / L12052 |
5 |
Hs.527119 |
phosphodiesterase 7A |
|
|
|
|
| PDGFB |
SIS |
NM_002608.1 / NM_033016.1 |
2 |
Hs.1976 |
platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) |
|
|
|
|
| PDGFRL |
PDGRL, PRLTS |
NM_006207.1 |
2 |
Hs.458573 |
platelet-derived growth factor receptor-like |
|
|
|
|
| PGK1 |
PGK1 |
NM_000291.2 |
6 |
Hs. 78771 |
phosphoglycerate kinase 1 |
|
|
|
|
| PGR |
PGR (#), NR3C3, PR |
NM_000926.3 |
7 |
Hs.368072 |
progesterone receptor |
|
|
|
|
| PHB2 |
BAP, BCAP37, Bap37, PNAS-141, REA, p22, prohibitin 2, GEFSP2, SCN1A |
NM_007273.3 |
7 |
Hs.504620 |
prohibitin 2 |
|
|
|
|
| PIK3C3 |
PIK3R3 |
NM_002647.2 |
6 |
Hs.464971 |
phosphoinositide-3-kinase, class 3 |
|
|
|
|
| PIK3R1 |
PIK3R1 (#), GRB1, p85-ALPHA |
NM_181523.1 / NM_181504.2 / NM_181524.1 |
7 |
Hs.132225 |
phosphoinositide-3-kinase, regulatory subunit, polypeptide 1 (p85 alpha) - TRANSCRIPT VARIANTS 1, 2, AND 3 |
|
|
|
|
| PLAU |
PLAU |
AF377330.2 |
7 |
Hs.77274 |
plasminogen activator, urokinase |
|
|
|
|
| PLAUR |
CD87, MO3, UPAR, UPKR |
X74039.1 |
3 |
Hs.466871 |
plasminogen activator, urokinase receptor |
|
|
|
|
| PLP2 |
A4, A4-LSB |
NM_002668.1 |
5 |
Hs.77422 |
proteolipid protein 2 (colonic epithelium-enriched) |
|
|
|
|
| PLTP |
PLTP |
NM_006227.2 |
2 |
Hs.439312 |
phospholipid transfer protein |
|
|
|
|
| PMS2L3 |
PMS5 |
D38437.1 |
1 |
Hs.278467 |
postmeiotic segregation increased 2-like 3 |
|
|
|
|
| PMVK |
HUMPMKI, PMK, PMK-PEN, PMKA, PMKI |
NM_006556.3 |
5 |
Hs.30954 |
phosphomevalonate kinase |
|
|
|
|
| PNUTL2 |
H5, SEPT4 |
NM_004574.2 / NM_080415.1 / NM_080416.1 / NM_080417.1 |
2 |
Hs.155524 |
peanut (Drosophila)-like 2 |
|
|
|
|
| POLA2 |
POLA2 |
NM_002689.2 |
2 |
Hs.81942 |
polymerase (DNA-directed), alpha (70kD) |
| Not approved by the HUGO/GDB Nomenclature Committee (April 1, 2003) |
|
|
|
| PON1 |
ESA, PON |
NM_000446.3 |
6 |
Hs.370995 |
paraoxonase 1 |
|
|
|
|
| POR |
CYPOR, NADPH OR |
NM_000941.2 |
1 |
Hs.354056 |
P450 (cytochrome) oxidoreductase |
|
|
|
|
| PPARBP |
PPARBP ($), ARC205, CRSP1, CRSP200, DRIP205, DRIP230, PBP, PPARGBP, RB18A, TRAP220, TRIP2 |
NM_004774.2 |
7 |
Hs.462956 |
PPAR binding protein |
|
|
|
|
| PPBP |
CTAP3, NAP-2, SCYB7, TGB, TGB1, THBGB, THBGB1 |
NM_002704.2 |
4 |
Hs.2164 |
pro-platelet basic protein |
|
|
|
|
| PPIA |
CYPA |
NM_021130.3 |
7 |
Hs.356331 |
peptidylprolyl isomerase A (cyclophilin A) - TRANSCRIPT VARIANT 1 |
|
|
|
|
| PPIF |
CYP3 |
NM_005729.3 |
7 |
Hs.381072 |
peptidylprolyl isomerase F (cyclophilin F) |
|
|
|
|
| PPIG |
CARS-Cyp, SRCyp, CYP |
NM_004792.2 |
2 |
Hs.470544 |
Clk-associating RS-cyclophilin |
|
|
|
|
| PPM1G |
PP2Cgamma, PPM1C, PPP2CG, PP2C gamma |
NM_177983.1 / NM_002707.3 |
3 |
Hs.17883 |
protein phosphatase 1G (formerly 2C), magnesium-dependent, gamma isoform |
|
|
|
|
| PPP1CC |
PPP1CC |
NM_002710.1 |
2 |
Hs.79081 |
protein phosphatase 1, catalytic subunit, gamma isoform |
|
|
|
|
| PPP2R1A |
PPP2R1 |
NM_014225.3 |
7 |
Hs.467192 |
protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), alpha isoform |
|
|
|
|
| PPP2R5C |
B56g, KIAA0044 |
NM_002719.2 |
3 |
Hs.368264 |
protein phosphatase 2, regulatory subunit B (B56), gamma isoform |
|
|
|
|
| PPP2R5D |
PPP2R5D |
NM_006245.2 / NM_180976.1 / NM_180977.1 |
3 |
Hs.533308 |
protein phosphatase 2, regulatory subunit B (B56), delta isoform |
|
|
|
|
| PPP2R5E |
PPP2R5E |
NM_006246.2 |
3 |
Hs.334868 |
protein phosphatase 2, regulatory subunit B (B56), epsilon isoform |
|
|
|
|
| PPP3CA |
CALN, CALNA, CCN1, CAN, CNA1, PPP2B |
NM_000944.2 |
3 |
Hs.435512 |
protein phosphatase 3 (formerly 2B), catalytic subunit, alpha isoform (calcineurin A alpha) |
|
|
|
|
| PPP6C |
PPP6 |
NM_002721.3 |
2 |
Hs. 80324 |
protein phosphatase 6, catalytic subunit |
|
|
|
|
| PRDX4 |
PRDX4 (#), AOE37-2, AOE372 |
NM_006406.1 |
7 |
Hs.83383 |
peroxiredoxin 4 |
|
|
|
|
| PRKCL2 |
PRK2 |
NM_006256.2 |
4 |
Hs.440833 |
protein kinase C-like 2 |
|
|
|
|
| PRKCSH |
G19P1, PPKCSH |
NM_002743.2; NM_001001329.1 |
3 |
Hs.512640 |
protein kinase C substrate 80K-H |
|
|
|
|
| PRKCZ |
PKC2 |
NM_002774.4 |
5 |
Hs.496255 |
protein kinase C, zeta |
|
|
|
|
| PRKDC |
DNAPK, XRCC7, HYRC1 |
NM_006904.6 |
7 |
Hs.491682 |
protein kinase, DNA-activated, catalytic polypeptide |
|
|
|
|
| PRMT1 |
ANM1, HCP1, HMT2, IR1B4, HRMT1L2 |
NM_001536.2 / NM_198319.1 / NM_198318.1 |
4 |
Hs.20521 |
HMT1 (hnRNP methyltransferase, S. cerevisiae)-like 2 |
|
|
|
|
| PRNP |
CJD, PRIP, ASCR |
NM_000311.3; NM_183079.2 |
7 |
Hs.472010 |
prion protein (p27-30) (Creutzfeld-Jakob disease, Gerstmann-Strausier-Scheinker syndrome) - TRANSCRIPT VARIANTS 1 AND 2 |
|
|
|
|
| PROM1 |
PROM1 ($), AC133, CD133, PROML1 |
NM_006017.1 |
7 |
Hs.479220 |
prominin 1 |
|
|
|
|
| PSCA |
PSCA |
NM_005672.3 |
6 |
Hs.379010 |
prostate stem cell antigen |
|
|
|
|
| PSMD8 |
HIP6, HYPF, Nin1p, S14, p31 |
NM_002812.3 |
4 |
Hs.78466 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 8 |
|
|
|
|
| PTCH |
BCNS, HPE7, NBCCS, PTCH1 |
NM_000264.2 |
3 |
Hs.494538 |
patched (Drosophila) homolog |
|
|
|
|
| PTGS2 |
COX2, COX-2 |
NM_000963.1 |
3 |
Hs.196384 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
|
|
|
| PTMS |
PTMS |
NM_002824.4 |
5 |
Hs.504613 |
parathymosin |
|
|
|
|
| PTP4A2 |
PTP4A2 (#), HH13, HH-7-2, HU-PP-1, OV-1, PRL-2, PRL2, PTP4A, PTPCAAX2, ptp-IV1a, ptp-iv1b |
NM_080391.2; NM_080392.2 |
7 |
Hs.470477 |
protein tyrosine phosphatase type IVA, member 2 -TRANSCRIPT VARIANTS 1, 2, AND 3 |
|
|
|
|
| PTPN6 |
HCP, HCPH, PTP-1C, PTP1C, SHP-1 |
NM_002831.2 / NM_080548.1 / NM_080549.1 |
2 |
Hs.63489 |
protein tyrosine phosphatase, non-receptor type 6 |
|
|
|
|
| PTPRN |
IA-2, IA2, ICA3, ICA512 |
NM_002846.2 |
2 |
Hs.89655 |
protein tyrosine phosphatase, receptor type, N |
|
|
|
|
| PVRL2 |
HVEB, PRR2, PVRR2 |
NM_002856.1 |
4 |
Hs.326371 |
poliovirus receptor-related 2 (herpesvirus entry mediator B) |
|
|
|
|
| PXMP3 |
PAF1, PEX2, PMP3 |
NM_000318.2 |
7 |
Hs.437966 |
peroxisomal membrane protein 3 (35kD, Zellweger syndrome) |
|
|
|
|
| PYCARD |
CARD5,PYCARD,TMS1, ASC |
NM_013258.3 |
6 |
Hs.499094 |
apoptosis-associated speck-like protein containing a CARD |
|
TRANSCRIPT VARIANT 3: NM_145183.1 |
|
|
| RAB24 |
RAB24 |
BC010006 |
6 |
Hs.16258 |
similar to RAB24, member RAS oncogene family |
|
|
|
|
| RAB5A |
RAB5 |
NM_004162.3 |
3 |
Hs.475663 |
RAB5A, member RAS oncogene family |
|
|
|
|
| RAB5B |
RAB5B |
NM_002868.2 |
2 |
Hs.77690 |
RAB5B, member RAS oncogene family |
|
|
|
|
| RAB6B |
RAB6B |
NM_016577.3 |
6 |
Hs.147164 |
RAB6B, member of RAS oncogene family |
|
|
|
|
| RAB9A |
RAB9 |
NM_004251.3 |
2 |
Hs.495704 |
RAB9A, member RAS oncogene family |
|
|
|
|
| RABIF |
MSS4, RASGFR3, RASGRF3, mss4 |
NM_002871.3 |
2 |
Hs.90875 |
RAB interacting factor |
|
|
|
|
| RAD52 |
RAD52 |
NM_002879.2 / NM_134424.1 / NM_134423.1 / NM_134422.1 |
3 |
Hs.525220 |
RAD52 (S. cerevisiae) homolog |
|
|
|
|
| RAG1 |
RAG1 |
NM_000448.1 |
4 |
Hs.73958 |
recombination activating gene 1 |
|
|
|
|
| RAP1A |
KREV-1, KREV1, SMPG21RAP1A |
NM_002884.2 / NM_001010935.1 |
1 |
Hs.190334 |
RAP1A, member of RAS oncogene family |
|
|
|
|
| RAP1B |
K-REV, DKFZP586, H0723 |
NM_015646.4 / NM_001010942.1 |
2 |
Hs.369920 |
DKFZP586H0723 protein |
|
|
|
|
| RAP1GAP |
KIAA0474, KREV-1, SMGP21, RAP1GA1 |
NM_002885.1 |
5 |
Hs.433797 |
RAP1, GTPase activating protein 1 |
|
|
|
|
| RAP1GDS1 |
RAP1 |
X63465.1 |
2 |
Hs.7940 |
RAP1, GTP-GDP dissociation stimulator 1 |
|
|
|
|
| RARA |
NR1B1, RAR |
NM_000964.2 / NM_001024809.2 / NM_001033603.1 |
1 |
Hs.361071 |
Retinoic acid receptor, alpha |
|
|
|
|
| RASGRP1 |
CALDAG-GEFI, CALDAG-GEFII, RASGRP |
NM_005739.2 |
5 |
Hs.511010 |
RAS guanyl releasing protein 1 (calcium and DAG-regulated) |
|
|
|
|
| RB1 |
RB |
NM_000321.1 |
1 |
Hs.408528 |
retinoblastoma 1 (including osteosarcoma) |
|
|
|
|
| RBBP7 |
RBAP46, RbAp46 |
NM_002893.2 |
4 |
Hs.495755 |
retinoblastoma-binding protein 7 |
|
|
|
|
| RBL2 |
RB2, Rb2, p130, P130 |
NM_005611.2 |
1 |
Hs.513609 |
retinoblastoma-like 2 (p130) |
|
|
|
|
| RBMX |
RBMXP1, HNRNP-G, HNRPG |
NM_002139.2 |
2 |
Hs.146381 |
RNA binding motif protein, X chromosome, pseudogene 1 |
|
|
|
|
| RCC1 |
CHC1 |
NM_001269.3 |
4 |
Hs.469723 |
chromosome condensation 1 |
|
|
|
|
| REPS2 |
POB1 |
NM_004726.2 |
2 |
Hs.186810 |
RALBP1 associated Eps domain containing 2 |
|
|
|
|
| RERG |
RERG (#), MGC15754 |
NM_032918.1 |
7 |
Hs.199487 |
RAS-like, estrogen-regulated, growth-inhibitor |
|
|
|
|
| RFC5 |
RFC5 |
NM_007370.3 |
4 |
Hs.506989 |
replication factor C (activator 1) 5 (36.5kD) |
|
|
|
|
| RFTN1 |
KIAA0084, RAFTLIN |
NM_015150.1 |
6 |
Hs.98910 |
raft-linking protein |
|
|
|
|
| RNASE2 |
EDN, RNS2 |
NM_002934.2 |
9 |
Hs.728 |
Ribonuclease, Rnase A family, 2 |
|
|
|
|
| RND3 |
RHO8, RND3, Rho8, RhoE, ARHE |
NM_005168.3 |
2 |
Hs.6838 |
ras homolog gene family, member E |
|
|
|
|
| RORA |
NR1F1, ROR1, ROR2, ROR3, RZRA |
NM_002943.2 / NM_134260.1 / NM_134261.1 / NM_134262.1 |
5 |
Hs.167015 |
RAR-related orphan receptor A - TRANSCRIPT VARIANTS 1, 2, 3, AND 4 |
|
|
|
|
| RPA2 |
REPA2, RPA32 |
NM_002946.3 |
4 |
Hs.79411 |
replication protein A2 (32kD) |
|
|
|
|
| RPS26 |
RPS26 |
NM_001029.3 |
6 |
Hs.355957/ Hs.447562 |
ribosomal protein S26 |
|
|
|
|
| RPS6KA1 |
HU-1, RSK, RSK1 |
NM_002953.3 |
5 |
Hs.149957 |
ribosomal protein S6 kinase, 90kD, polypeptide 1 |
|
|
|
|
| RPS6KA2 |
HU-2, RSK, RSK3 |
NM_021135.4 |
4 |
Hs.301664 |
ribosomal protein S6 kinase, 90kD, polypeptide 2 |
|
|
|
|
| RPS6KA4 |
MSK2, RSK-B |
NM_003942.2 / NM_001006944.1 |
1 |
Hs.105584 |
Ribosomal protein S6 kinase, 90kD, polypeptide 4 |
|
|
|
|
| RQCD1 |
RCD1, RCD1+ |
D87957.1 |
2 |
Hs.293687 |
rcd1 (required for cell differentiation,Spombe) homolog 1 |
|
|
|
|
| RRM1 |
RR1 |
X59617.1 |
4 |
Hs.383396 |
ribonucleotide reductase M1 polypeptide |
|
|
|
|
| RTCD1 |
RPC, RPC1 |
NM_003729.1 |
6 |
Hs.484222 |
RTC domain containing 1 |
|
|
|
|
| RUVBL1 |
NMP238, TIP49 |
NM_003707.1 |
3 |
Hs.272822 |
RuvB (E coli homolog)-like 1 |
|
|
|
|
| RXRG |
RXRG |
NM_006917.3 |
7 |
Hs.26550 |
retinoid X receptor, gamma |
|
|
|
|
| RYK |
D3S3195 |
NM_001005861.2; NM_002958.3 |
2 |
Hs.79350 |
RYK-receptor like tyrosine kinase |
|
|
|
|
| S100A11 |
MLN70, S100C, CALG, Calgizzarin |
NM_005620.1 |
2 |
Hs.417004 |
S100 calcium-binding protein A11 (calgizzarin) |
|
|
|
|
| S100A12 |
CAAF1,CGRP,MRP6 |
NM_005621.1 |
9 |
Hs.19413 |
S100 calcium binding protein A12 (calgranulin c) |
|
|
|
|
| S100A3 |
S100E |
NM_002960.1 |
2 |
Hs.2961 |
S100 calcium-binding protein A3 |
|
|
|
|
| S100A8 |
CAGA,CFAG,MRP8 |
NM_002964.3 |
9 |
Hs.416073 |
S100 calcium-binding protein A8 |
|
|
|
|
| S100P |
S100P |
NM_005980.2 |
7 |
Hs.2962 |
S100 calcium-binding protein P |
|
|
|
|
| SAFB |
HET |
NM_002967.2 |
6 |
Hs.23978 |
scaffold attachment factor B |
|
|
|
|
| SAT1 |
SSAT, SAT |
NM_002970.1 |
6 |
Hs.28491 |
spermidine/spermine N1-acetyltransferase |
|
|
|
|
| SCNN1A |
SCNN1, ENaCa, ENaCalpha |
NM_001038.4 |
5 |
Hs.130989 |
sodium channel, nonvoltage-gated 1, alpha |
|
|
|
|
| SCUBE2 |
CEGP1 |
NM_020974.1 |
6 |
Hs.523468 |
CEGP1 protein |
| Not approved by the HUGO/GDB Nomenclature Committee |
|
|
|
| SDHA |
FP, SDH2, SDHF, SDH |
NM_004168.1 |
2 |
Hs.440475 |
succinate dehydrogenase complex, subunit A, flavoprotein (Fp) |
|
|
|
|
| SEC61B |
SEC61B |
NM_006808.2 |
5 |
Hs.191887 |
protein translocation complex beta |
|
|
|
|
| SELE |
ELAM, ELAM1, ESEL |
NM_000450.1 |
4 |
Hs.89546 |
selectin L (lymphocyte adhesion molecule 1) |
|
|
|
|
| SIVA |
CD27BP |
NM_006427.3 |
5 |
Hs.112058 |
CD27-binding (Siva) protein |
| Not approved by the HUGO/GDB Nomenclature Committee April 2, 2003 |
|
|
|
| SLC02A1 |
PGT, SLC21A2 |
NM_005630.1 |
6 |
Hs.518270 |
solute carrier family 21 (prostaglandin transporter), member 2 |
|
|
|
|
| SLC10A1 |
NTCP, NTCP1 |
NM_003049.1 |
5 |
Hs.952 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
|
|
|
|
| SLC10A2 |
NTCP2 |
NM_000452.1 |
7 |
Hs.194783 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 2 |
|
|
|
|
| SLC15A2 |
PEPT2 |
NM_021082.2 |
4 |
Hs.518089 |
solute carrier family 15 (H+/peptide transporter), member 2 |
|
|
|
|
| SLC16A1 |
SLC16A1 |
NM_003051.3 |
7 |
Hs.75231 |
solute carrier family 16 (monocarboxylic acid transporters), member 1 |
|
|
|
|
| SLC17A3 |
NPT3, NPT4 |
NM_006632.1 |
4 |
Hs.327179 |
solute carrier family 17 (sodium phosphate), member 3 |
|
|
|
|
| SLC1A3 |
EAAT1, GLAST, GLAST1, EAA1 |
NM_004172.3 |
3 |
Hs.481918 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
|
|
|
|
| SLC1A6 |
EAAT4 |
NM_005071.1 |
7 |
Hs.515217 |
solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 |
|
|
|
|
| SLC20A1 |
GLVR1, Glvr-1, PiT-1 |
NM_005415.3 |
5 |
Hs.187946 |
solute carrier family 20 (phosphate transporter), member 1 |
|
|
|
|
| SLC22A1 |
OCT1 |
NM_003057.2 |
6 |
Hs.117367 |
solute carrier family 22 (organic cation transporter), member 1- TRANSCRIPT VARIANT 1 |
|
|
|
|
| SLC22A6 |
OAT1, PAHT, ROAT1 |
NM_004790.3 |
7 |
Hs.369252 |
solute carrier family 22 (organic cation transporter), member 6 - TRANSCRIPT VARIANT 1 |
|
TRANSCRIPT VARIANT 4: NM_153278.1 |
|
|
| SLC25A17 |
PMP34 |
NM_006358.2 |
5 |
Hs.474938 |
solute carrier family 25 (mitochondrial carrier; peroxisomal membrane protein, 34kD), member 17 |
|
|
|
|
| SLC25A4 |
ANT1, PEO2, PEO3, T1 |
NM_001151.2 |
5 |
Hs.246506 |
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
|
|
|
|
| SLC29A1 |
ENT1 |
NM_004955.1 |
4 |
Hs.25450 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
|
|
|
| SLC2A1 |
SLC2A1 |
NM_006516.1 |
7 |
Hs.473721 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
|
|
|
| SLC2A3 |
GLUT3 |
NM_006931.1 |
4 |
Hs.419240 |
solute carrier family 2 (facilitated glucose transporter), member 3 |
|
|
|
|
| SLC31A2 |
COPT2, CTR2, Hctr2, SLC31A2 |
NM_001860.2 |
6 |
Hs.24030 |
solute carrier family 31 (copper transporters), member 2 (hCTR2) |
|
|
|
|
| SLC39A6 |
LIV-1 |
NM_012319.2 |
7 |
Hs.79136 |
solute carrier family 39 (metal ion, ZINC transport), member 6 |
|
|
|
|
| SMAD1 |
MADH1, SMAD1, BSP1, JV4-1, MADR1 |
NM_005900.2 / NM_001003688.1 |
4 |
Hs.519005 |
SMAD, mothers against DPP homolog 1 (Drosophila) |
|
|
|
|
| SMAD2 |
SMAD2 (#), MADH2 #, JV18, SMAD2, MADR2, |
NM_005901.4; NM_001003652.2 |
7 |
Hs.465061 |
MAD, mothers against decapentaplegic homolog 2 (Drosophila) - TRANSCRIPT VARIANTS 1 AND 2 |
|
|
|
|
| SNCA |
NACP, PARK1, PD1 |
NM_007308.1 / NM_000345.2 |
3 |
Hs.271771 |
synuclein, alpha (non A4 component of amyloid precursor) |
|
|
|
|
| SND1 |
LYT10, NFKB2, p100, |
NM_014390.2 |
4 |
Hs.122523 |
EBNA-2 co-activator (100kD) |
| Not approved by the HUGO/GDB Nomenclature Committee 07/06/04 |
|
|
|
| SOD1 |
CU/ZN-SOD, ALS, ALS1 |
NM_000454.4 |
1 |
Hs.443914 |
superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) |
|
|
|
|
| SOD3 |
EC-SOD |
NM_003102.2 |
7 |
Hs.2420 |
superoxide dismutase 3, extracellular |
|
|
|
|
| SP1 |
TSFP1, SP-1 |
J03133.1 |
3 |
Hs.524461 |
Sp1 transcription factor |
|
|
|
|
| SPARC |
ON |
NM_003118.2 |
1 |
Hs.111779 |
secreted protein, acidic, cysteine-rich (osteonectin) |
|
|
|
|
| SPDEF |
PDEF |
NM_012391.1 |
7 |
Hs.485158 |
SAM pointed domain containing ets transcription factor |
|
|
|
|
| SPINT2 |
HAI-2, HAI2, KOP, Kop |
NM_021102.2 |
3 |
Hs.31439 |
serine protease inhibitor, Kunitz type, 2 |
|
|
|
|
| SQLE |
SQLE (#), ERG1 |
NM_003129.3 |
7 |
Hs.71465 |
squalene epoxidase |
|
|
|
|
| SRP14 |
SRP14 |
NM_003134.2 |
3 |
Hs.533732 |
signal recognition particle 14kD (homologous Alu RNA-binding protein) |
|
|
|
|
| SSBP1 |
SSBP |
NM_003143.1 |
3 |
Hs.490394 |
single-stranded DNA-binding protein |
|
|
|
|
| ST13 |
FAM10A1, HIP, HSPABP, HSPABP1, SNC6, p48 |
NM_003932.3 |
2 |
Hs.474940 |
suppression of tumorigenicity 13 (colon carcinoma) (Hsp70-interacting protein) |
|
|
|
|
| ST8SIA2 |
ST8SIA-II, STX, SIAT8B |
NM_006011.3 |
4 |
Hs.302341 |
sialyltransferase 8 (alpha-2, 8-sialytransferase) B |
|
|
|
|
| STARD10 |
SDCCAG28, CGI-52, NY-CO-28, PCTP2 |
NM_006645.2 |
5 |
Hs.188606 |
START domain containing 10 |
|
|
|
|
| STARD3 |
MLN64 |
NM_006804.2 |
7 |
Hs.77628 |
steroidogenic acute regulatory protein related |
|
|
|
|
| STAT3 |
APRF |
L29277.1 |
2 |
Hs.463059 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
|
|
|
| STK19 |
D6S60, D6S60E, D6S974E, G11, RP1 |
NM_004197.1 / NM_032454.1 |
2 |
Hs.485102 |
serine/threonine kinase 19 |
|
|
|
|
| STK4 |
KRS2, MST1 |
NM_006282.2 |
5 |
Hs.472838 |
serine/threonine kinase 4 |
|
|
|
|
| STX1A |
STX1, HPC-1 |
NM_004603.2 |
1 |
Hs.488683 |
syntaxin 1A (brain) |
|
|
|
|
| SULT1A1 |
P-PST, PST, STP, STP1 |
NM_001055.2 / NM_177529.1 / NM_177530.1 / NM_177534.1 |
1 |
Hs.142 |
sulfotransferase family 1A, phenol-preferring, member 1 |
|
|
|
|
| SULT1A3 |
STM, TL-PST, PSTT |
NM_003166.3 / NM_177552.2 / NM_001017387.1 |
1 |
Hs.460587 |
sulfotransferase family 1A, phenol-preferring, member3 |
|
|
|
|
| SULT2A1 |
DHEA-ST, HST, STD, DHEA PST |
NM_003167.2 |
1 |
Hs.515835 |
sulfotransferase family 2A, dehydroepiandrosterone (DHEA) -preferring, member 1 |
|
|
|
|
| SUMO1 |
GMP1, PIC1, SMT3, UBL1, SUM01, SUMO1 |
NM_003352.4; NM_001005782.1 |
6 |
Hs.81424 |
ubiquitin-like 1 (sentrin) |
|
|
|
|
| SYBL1 |
TI-VAMP, VAMP-7, VAMP7 |
NM_005638.3 |
4 |
Hs.24167 |
synaptobrevin-like 1 |
|
|
|
|
| TCF7L2 |
TCF-4, TCF4 |
NM_030756.1 |
2 |
Hs.501080 |
transcription factor 7-like 2 (T-cell specific, HMG-box) |
|
|
|
|
| TEAD1 |
TCF13, TEF-1, TEF1 |
M63896.1 |
5 |
Hs.153408 |
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
|
|
|
|
| TEK |
TIE-2, TIE2, VMCM, VMCM1 |
NM_000459.2 |
2 |
Hs.89640 |
TEK tyrosine kinase, endothelial (venous malfomations, multiple cutaneous and mucosal) |
|
|
|
|
| TERT |
EST2, TCS1, TP2, TRT, hEST2, hTERT |
NM_003219.2 |
2 |
Hs.492203 |
telomerase reverse transcriptase |
|
|
|
|
| TF |
TF |
NM_001063.2 |
6 |
Hs.518267 |
transferrin |
|
|
|
|
| TFDP2 |
DP-2, DP2 |
NM_006286.1 |
1 |
Hs.379018 |
transcription factor Dp-2 (E2F dimerization partner2) |
|
|
|
|
| TGFBR2 |
HNPCC6 |
NM_003242.5 |
3 |
Hs.82028 |
transforming growth factor, beta receptor I (activin A receptor type II-like kinase, 53kD) |
|
|
|
|
| TGIF |
HPE4, TGIF1 |
NM_003244.2 |
3 |
Hs.373550 |
TG-interacting factor (TALE family homeobox) |
|
|
|
|
| TGM1 |
ICR2, KTG, LI1, TGASE, TGASE1, TGASE-1 |
NM_000359.2 |
2 |
Hs.508950 |
transglutaminase 1 (K polypeptide epidermal type I, protein-glutamine-gamma-glutamyltransferase) |
|
|
|
|
| TGM2 |
TGASE-2, TGASE2 |
NM_004613.2 / NM_198951.1 |
1 |
Hs.517033 |
transglutaminase 1 (K polypeptide epidermal type I, protein-glutamine-gamma-glutamyltransferase) |
|
|
|
|
| TGOLN2 |
TGN38, TGN46, TGN48, TGN51, TTGN2 |
NM_006464.2 |
4 |
Hs.14894 |
trans-Golgi network protein (46, 48, 51kD isoforms) |
|
|
|
|
| THPO |
MGDF, MPLLG, TPO |
NM_000460.2 |
4 |
Hs.1166 |
thrombopoietin |
|
|
|
|
| TIMP2 |
TIMP-2 |
NM_003255.4 |
2 |
Hs.104839 |
tissue inhibitor of metalloproteinase 2 |
|
|
|
|
| TIRAP |
MAL |
NM_052887.2 |
7 |
Hs.524130 |
toll-interleukin 1 receptor (TIR) domain-containing adapter protein - TRANSCRIPT VARIANT 1 |
|
|
|
|
| TLOC1 |
Dtrp1, HTP1 |
NM_003262.3 |
4 |
Hs.529591 |
translocation protein 1 |
|
|
|
|
| TLR2 |
TIL4, TOLL-LIKE RECEPTOR 2 |
NM_003264.3 |
9 |
Hs.519033 |
TOLL-LIKE RECEPTOR 2 |
|
|
|
|
| TLR4 |
hToll,CD284 ANTIGEN |
NM_003266.2/NM_138554.1/NM_138556.1/NM_138557.1 |
9 |
Hs.174312 |
TOLL-LIKE RECEPTOR 4 |
|
|
|
|
| TM4SF5 |
TM4SF5 |
NM_003963.2 |
5 |
Hs.184194 |
transmembrane 4 superfamily member 5 |
|
|
|
|
| TMPRSS2 |
TMPRSS2 |
NM_005656.2 |
6 |
Hs.318545 |
transmembrane protease, serine 2 |
|
|
|
|
| TMSB4X |
PTMB4, TMSB4 |
NM_021109.2 |
5 |
Hs.522584 |
thymosin, beta 4, X chromosome |
|
|
|
|
| TNF |
TNF-alpha, DIF, TNFSF2, TNFA |
NM_000594.2 |
1 |
Hs.241570 |
tumor necrosis factor (TNF superfamily, member 2) |
|
|
|
|
| TNFAIP1 |
B61, EDP1 |
NM_021137.3 |
3 |
Hs.76090 |
tumor necrosis factor, alpha-induced protein 1 (endothelial) |
|
|
|
|
| TNFAIP6 |
TNFAIP6 |
NM_007115.2 |
7 |
Hs.437322 |
tumor necrosis factor, alpha-induced protein 6 |
|
|
|
|
| TNFRSF10C |
TRAILR3, DCR1, DR6, DcR1, LIT, TRID |
NM_003841.2 |
6 |
Hs.119684 |
tumor necrosis factor receptor superfaimily, member 10c, decoy without an intracellular domian |
|
|
|
|
| TNFRSF1A |
CD120a, FPF, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR60 |
NM_001065.2 |
1 |
Hs.279594 |
tumor necrosis factor receptor superfamily, member 1A |
|
|
|
|
| TNFSF11 |
CD254, ODF, OPGL, OPGLG, RANKL, TRANCE, hRANKL2, sOdf |
NM_003701.2; NM_033012.2 |
|
Hs.333791 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
|
|
|
| TOP3A |
TOP3 |
NM_004618.3 |
7 |
Hs.435124 |
topoisomerase (DNA) III alpha |
|
|
|
|
| TP53 |
p53, P53 |
NM_000546.3 |
1 |
Hs.408312 |
tumor protein p53 (Li-Fraumeni syndrome) |
|
|
|
|
| TP53BP2 |
BBP, PPP1R13A |
NM_005426.2 |
2 |
Hs.523968 |
tumor protein p53-binding protein, 2 |
|
|
|
|
| TP73L |
TP63, p63, EEC, KET |
NM_003722.3 |
6 |
Hs.137569 |
tumor protein p63 |
|
|
|
|
| TPBG |
5T4-ANTIGEN |
NM_006670.3 |
6 |
Hs. 82128 |
trophoblast glycoprotein |
|
|
|
|
| TRAF4 |
CART1, MLN62 |
NM_004295.2 |
3 |
Hs.8375 |
TNF receptor-associated factor 4 |
|
|
|
|
| TRAFD1 |
FLN29 |
NM_006700.1 |
4 |
Hs.5148 |
FLN29 gene product |
|
|
|
|
| TRIB2 |
GS3955, T2R10, TRIB2 |
NM_021643.1 |
4 |
Hs.467751 |
tribbles homolog 2 |
|
|
|
|
| TRIM21 |
RO52, SSA1 |
NM_003141.3 |
4 |
Hs.532357 |
Sjogren syndrome antigen A1 (52kD, ribonucleoprotein autoantigen SS-A/Ro) |
|
|
|
|
| TRIM29 |
ATDC |
NM_058193.1 |
5 |
Hs.504115 |
tripartite motif-containing 29 |
|
|
|
|
| TSC22D3 |
DSIPI, DIP, DKFZp313A1123, GILZ, TSC-22R, hDIP |
NM_001015881.1; NM_004089.3; NM_198057.2 |
|
Hs.522074 |
TSC22 domain family, member 3 |
|
|
|
|
| TSPAN6 |
T245, TM4SF6 |
NM_003270.2 |
4 |
Hs.43233 |
transmembrane 4 superfamily member 6 |
|
|
|
|
| TST |
RDS |
NM_003312.4 |
6 |
Hs.474783 |
thiosulfate sulfurtransferase (rhodanese) |
|
|
|
|
| TTR |
PALB |
NM_000371.1 |
4 |
Hs.427202 |
transthyretin (prealbumin, amyloidosis type I) |
|
|
|
|
| TUBA4 |
FLJ13940 |
NM_025019.1 |
7 |
Hs.471416 |
tubulin, alpha 4 |
|
|
|
|
| TYMS |
TYMS (%), HsT422, TMS, TS, Tsase |
NM_001071.1 |
7 |
Hs.369762 |
thymidylate synthetase |
|
|
|
|
| UBC |
UBC (#), HMG20 |
NM_021009.3 |
9 |
Hs.520348 |
ubiquitin C |
|
|
|
|
| UCP2 |
SLC25A8 |
NM_003355.2 |
7 |
Hs.80658 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
|
|
|
| UGP2 |
UGPP2 |
NM_006759.3; NM_001001521.1 |
6 |
Hs.77837 |
UDP-glucose pyrophosphorylase 2 |
|
|
|
|
| UGT1A1 |
GNT1, UGT1, UGT1A, Gluct1 |
NM_000463.2 |
1 |
Hs.124112 |
UDP glycosyltransferase 1 |
|
|
|
|
| UGT1A4 |
HUG-BR2, UGT1D |
NM_007120.2 |
1 |
Hs.278892 |
UDP-glucuronosyltransferase 2 family, polypeptide B |
|
|
|
|
| VDAC1 |
VDAC |
NM_003374.1 |
4 |
Hs.519320 |
voltage-dependent anion channel 1 |
|
|
|
|
| VEGF |
VEGF-A, VEGFA |
NM_003376.4 |
2 |
Hs.73793 |
vascular endothelial growth factor |
|
|
|
|
| VIM |
VIMENTIN |
NM_003380.2 |
2 |
Hs.533317 |
vimentin |
|
|
|
|
| VIP |
VIP |
NM_003381.2 |
5 |
Hs.53973 |
vasoactive intestinal peptide |
|
|
|
|
| VLDLR |
VLDLR |
NM_003383.3 |
7 |
Hs.370422 |
very low density lipoprotein receptor |
|
|
|
|
| VPS72 |
YL-1, YL1, TCFL1 |
NM_005997.1 |
3 |
Hs.2430 |
transcription factor-like 1 |
|
|
|
|
| WFDC2 |
HE4 |
NM_006103.3 / NM_080733.1 / NM_080734.1 |
5 |
Hs.2719 |
WAP four-disulfide core domain 2 |
|
|
|
|
| WNT1 |
INT1 |
NM_005430.2 |
5 |
Hs.248164 |
wingless-type MMTV integration site family member 1 |
|
|
|
|
| WNT10B |
WNT12 |
NM_003394.2 |
6 |
Hs.91985 |
wingless-type MMTV integration site family member 10B |
|
|
|
|
| WNT2B |
WNT13, XWNT2 |
NM_004185.2 / NM_024494.1 |
4 |
Hs.258575 |
wingless-type MMTV integration site family, member 2B |
|
|
|
|
| XBP1 |
TREB5, XBP2 |
NM_005080.2 |
5 |
Hs.437638 |
X-box binding protein 1 |
|
|
|
|
| XPA |
XPAC |
NM_000380.2 |
5 |
Hs.288867 |
xeroderma pigmentosum, complementation group A |
|
|
|
|
| XPC |
XPC/p125, XPCC |
NM_004628.3 |
7 |
Hs.475538 |
xeroderma pigmentosum, complementation group C |
|
|
|
|
| XRCC1 |
XRCC1 |
NM_006297.1 |
5 |
Hs.98493 |
X-ray repair complementing defective repair in Chinese hamster cells 1 |
|
|
|
|
| ZNF198 |
RAMP, FIM, SCLL, L2DTL, DTL |
NM_016448.1 |
6 |
Hs.126774 |
RA-regulated nuclear matrix-associated protein |
|
|
|
|
